data_1hz3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hz3 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt . . . . . 0 CA--C 1.567 1.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.57 0.91 0.3 Allowed 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.3 t -68.27 99.06 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 CA-C-N 123.569 2.895 . . . . 0.0 118.293 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -89.96 -14.15 34.69 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 129.068 2.947 . . . . 0.0 115.057 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -112.26 -1.67 15.09 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.27 -90.3 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -130.07 9.81 5.33 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 121.042 3.719 . . . . 0.0 121.042 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.51 31.93 0.66 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.253 2.297 . . . . 0.0 110.217 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p 158.16 -27.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 C-N-CA 129.599 3.159 . . . . 0.0 109.855 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.23 66.35 0.79 Allowed Glycine 0 N--CA 1.49 2.247 0 CA-C-N 122.68 2.491 . . . . 0.0 109.159 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.9 m 49.12 49.0 20.27 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 118.097 2.628 . . . . 0.0 118.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -174.44 70.77 0.03 OUTLIER 'General case' 0 CA--C 1.577 2.005 0 O-C-N 119.396 -2.065 . . . . 0.0 110.372 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 57.72 4.51 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.721 -1.862 . . . . 0.0 108.665 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 3.454 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -171.003 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.512 2.653 0 N-CA-C 118.068 2.618 . . . . 0.0 118.068 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -69.85 -9.27 54.16 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.7 t -56.45 123.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-O 124.013 1.863 . . . . 0.0 115.983 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -115.86 -3.18 12.21 Favored 'General case' 0 CA--C 1.585 2.298 0 C-N-CA 130.748 3.619 . . . . 0.0 113.756 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.78 -3.47 6.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.95 -102.27 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.91 10.19 5.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.41 44.86 1.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 122.503 2.411 . . . . 0.0 108.132 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p 150.68 -33.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 C-N-CA 130.39 3.476 . . . . 0.0 109.311 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 58.81 0.84 Allowed Glycine 0 N--CA 1.49 2.29 0 CA-C-N 121.819 2.1 . . . . 0.0 111.992 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m 54.01 44.42 29.35 Favored 'General case' 0 CA--C 1.59 2.497 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.59 63.27 0.05 Allowed 'General case' 0 CA--C 1.583 2.241 0 O-C-N 119.081 -2.262 . . . . 0.0 113.284 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -83.73 66.28 8.96 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 118.502 -2.624 . . . . 0.0 109.002 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.633 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -171.433 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 tp -65.91 -53.89 33.5 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.984 2.629 . . . . 0.0 117.425 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.3 t -40.28 130.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 126.386 2.993 . . . . 0.0 116.572 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.04 7.59 7.29 Favored 'General case' 0 CA--C 1.584 2.252 1 CA-C-N 107.775 -4.284 . . . . 0.0 114.563 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -128.74 -43.61 1.37 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.81 2.044 . . . . 0.0 113.389 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.54 -95.32 0.23 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 15' ' ' VAL . 4.9 tt0 -136.72 14.61 3.14 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 120.329 3.455 . . . . 0.0 120.329 -174.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -85.23 23.81 1.22 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 122.5 2.409 . . . . 0.0 110.672 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 13' ' ' GLU . 11.6 p 168.05 -27.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 C-N-CA 131.185 3.794 . . . . 0.0 109.445 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.49 70.74 1.14 Allowed Glycine 0 N--CA 1.49 2.295 0 CA-C-N 122.944 2.611 . . . . 0.0 111.11 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m 51.54 39.41 24.7 Favored 'General case' 0 CA--C 1.592 2.592 0 N-CA-C 119.936 3.31 . . . . 0.0 119.936 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -173.78 78.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 118.693 -2.504 . . . . 0.0 111.643 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -104.65 70.43 0.94 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.595 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 pttm . . . . . 0 N--CA 1.513 2.678 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -97.96 3.07 49.61 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 119.037 2.977 . . . . 0.0 119.037 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 12' ' ' ALA . 3.7 t -72.72 94.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 N-CA-C 120.081 3.363 . . . . 0.0 120.081 -169.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -81.32 -23.08 38.05 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 128.648 2.779 . . . . 0.0 114.666 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -100.65 -16.91 17.26 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.402 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -139.72 -82.91 0.26 Allowed 'General case' 0 CA--C 1.555 1.158 1 N-CA-C 123.12 4.489 . . . . 0.0 123.12 -172.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 15' ' ' VAL . 11.9 tt0 -127.23 -1.12 6.39 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.481 3.882 . . . . 0.0 121.481 -171.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.21 25.98 0.22 Allowed 'General case' 0 N--CA 1.521 3.109 0 CA-C-N 123.086 2.676 . . . . 0.0 111.898 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 13' ' ' GLU . 3.7 p 164.91 -27.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.033 0 C-N-CA 129.642 3.177 . . . . 0.0 110.643 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.93 68.66 0.77 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 122.459 2.39 . . . . 0.0 108.074 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.1 m 46.03 45.78 12.39 Favored 'General case' 0 CA--C 1.593 2.612 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -171.39 72.34 0.05 OUTLIER 'General case' 0 CA--C 1.577 2.018 0 O-C-N 119.39 -2.069 . . . . 0.0 110.36 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.9 58.02 4.83 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 119.953 -1.717 . . . . 0.0 109.068 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.608 0 N-CA-C 105.968 -2.853 . . . . 0.0 105.968 -170.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.566 1.585 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -173.36 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 125.302 1.441 . . . . 0.0 111.817 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -16.25 101.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.589 2.453 0 C-N-CA 130.685 3.594 . . . . 0.0 118.067 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -100.45 -4.01 29.75 Favored 'General case' 0 CA--C 1.585 2.292 1 CA-C-N 107.562 -4.381 . . . . 0.0 114.01 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -119.8 -8.8 9.82 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 127.559 2.344 . . . . 0.0 116.133 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.94 -86.36 0.11 Allowed 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 119.412 3.115 . . . . 0.0 119.412 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -125.49 4.32 7.63 Favored 'General case' 0 N--CA 1.498 1.937 1 N-CA-C 122.591 4.293 . . . . 0.0 122.591 -172.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.81 9.11 4.48 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 121.77 2.077 . . . . 0.0 112.737 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p 176.51 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 C-N-CA 129.737 3.215 . . . . 0.0 111.335 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.68 58.73 0.89 Allowed Glycine 0 N--CA 1.494 2.529 0 CA-C-N 122.869 2.577 . . . . 0.0 109.789 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p 52.63 50.6 17.81 Favored 'General case' 0 CA--C 1.589 2.468 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -173.7 68.82 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.902 0 O-C-N 119.566 -1.959 . . . . 0.0 110.384 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.76 59.99 3.34 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.802 -1.811 . . . . 0.0 108.463 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.151 0 N-CA-C 106.368 -2.693 . . . . 0.0 106.368 -172.688 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.0 tttp . . . . . 0 CA--C 1.567 1.61 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.54 -43.47 0.19 Allowed 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 t -25.48 105.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.591 2.537 0 CA-C-O 127.292 3.425 . . . . 0.0 116.77 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -106.41 7.06 30.91 Favored 'General case' 0 CA--C 1.577 2.001 2 CA-C-N 107.077 -4.601 . . . . 0.0 114.658 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -130.6 -57.39 1.06 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 125.933 1.693 . . . . 0.0 113.12 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.08 -80.62 0.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' VAL . 2.5 tt0 -149.12 12.93 0.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 120.966 3.691 . . . . 0.0 120.966 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -85.68 39.09 0.78 Allowed 'General case' 0 N--CA 1.516 2.83 0 CA-C-N 122.543 2.429 . . . . 0.0 108.671 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLU . 4.3 p 152.43 -28.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.091 0 C-N-CA 130.63 3.572 . . . . 0.0 109.021 -174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.16 55.43 3.1 Favored Glycine 0 N--CA 1.491 2.365 0 CA-C-N 122.685 2.493 . . . . 0.0 109.596 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m 63.6 95.38 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.155 1.382 . . . . 0.0 112.648 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 149.52 47.77 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.139 0 C-N-CA 127.4 2.28 . . . . 0.0 111.239 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 63.4 3.22 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 117.206 -3.434 . . . . 0.0 103.737 175.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.58 4.103 0 N-CA-C 105.524 -3.03 . . . . 0.0 105.524 -169.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 tptt . . . . . 0 CA--C 1.574 1.899 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 pp -142.9 1.69 1.3 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 119.201 3.038 . . . . 0.0 119.201 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.58 99.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.249 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 -172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 19' ' ' LYS . 23.2 p90 -91.58 -0.17 57.56 Favored 'General case' 0 CA--C 1.58 2.123 0 C-N-CA 128.979 2.912 . . . . 0.0 115.123 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -122.7 -36.01 2.97 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.66 -99.93 0.4 Allowed 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 119.997 3.332 . . . . 0.0 119.997 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 15' ' ' VAL . 1.2 tm-20 -132.49 14.42 4.51 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 -173.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -82.81 20.28 1.19 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 122.288 2.313 . . . . 0.0 112.421 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' A' ' 13' ' ' GLU . 6.0 p 169.13 -24.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.035 0 C-N-CA 130.314 3.446 . . . . 0.0 109.581 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.92 69.55 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-N 123.012 2.642 . . . . 0.0 109.339 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 m 50.51 46.24 25.66 Favored 'General case' 0 CA--C 1.595 2.677 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -174.11 72.42 0.03 OUTLIER 'General case' 0 CA--C 1.581 2.162 0 O-C-N 118.797 -2.44 . . . . 0.0 111.01 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 10' ' ' PHE . 2.4 tpmt? -88.52 65.08 7.73 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 119.509 -1.995 . . . . 0.0 108.581 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.686 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -172.114 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 123.318 1.533 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tp -159.32 -56.55 0.06 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.822 -1.174 . . . . 0.0 111.368 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG11 ' H ' ' A' ' 12' ' ' ALA . 42.5 t -51.13 103.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 126.864 3.221 . . . . 0.0 117.405 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -88.56 -9.5 52.06 Favored 'General case' 0 CA--C 1.577 2.007 0 CA-C-N 108.546 -3.934 . . . . 0.0 114.811 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -115.46 -14.89 11.54 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 127.191 2.196 . . . . 0.0 116.227 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.473 ' H ' HG11 ' A' ' 9' ' ' VAL . . . -147.64 -70.5 0.23 Allowed 'General case' 0 CA--C 1.562 1.44 1 N-CA-C 124.291 4.923 . . . . 0.0 124.291 -174.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 15' ' ' VAL . 4.8 mt-10 -129.52 -17.56 3.68 Favored 'General case' 0 N--CA 1.504 2.241 1 N-CA-C 126.967 5.914 . . . . 0.0 126.967 -170.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.2 27.7 0.67 Allowed 'General case' 0 N--CA 1.52 3.055 0 CA-C-N 123.806 3.003 . . . . 0.0 111.549 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 13' ' ' GLU . 8.4 p 176.45 -32.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 C-N-CA 128.902 2.881 . . . . 0.0 110.66 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.92 65.18 0.79 Allowed Glycine 0 N--CA 1.489 2.17 0 CA-C-N 121.766 2.076 . . . . 0.0 110.558 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m 50.91 45.9 26.94 Favored 'General case' 0 CA--C 1.586 2.354 0 N-CA-C 117.884 2.55 . . . . 0.0 117.884 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -173.17 74.14 0.04 OUTLIER 'General case' 0 CA--C 1.576 1.949 0 O-C-N 119.669 -1.894 . . . . 0.0 111.094 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.71 62.78 3.29 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 119.942 -1.724 . . . . 0.0 107.454 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.477 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 -171.745 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.85 -52.64 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.069 0.948 . . . . 0.0 112.38 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 t -53.44 148.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 CA-C-O 124.674 2.178 . . . . 0.0 115.682 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 -51.15 2.21 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 111.215 -2.721 . . . . 0.0 109.725 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -91.72 10.41 28.46 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.32 -109.52 0.17 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 123.696 2.953 . . . . 0.0 116.688 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -125.88 17.53 7.96 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.89 1.66 55.33 Favored 'General case' 0 CA--C 1.599 2.843 0 O-C-N 119.82 -1.8 . . . . 0.0 110.351 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 m -151.48 -40.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.904 0 C-N-CA 129.301 3.04 . . . . 0.0 110.085 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.85 62.31 0.56 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.93 1.241 . . . . 0.0 114.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.5 t 35.54 45.84 0.26 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 119.612 3.19 . . . . 0.0 119.612 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -101.65 -1.58 32.36 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.3 pttt 67.44 -49.99 0.5 Allowed 'General case' 0 N--CA 1.515 2.81 0 C-N-CA 128.059 2.544 . . . . 0.0 112.032 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 2.883 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.6 175.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptt . . . . . 0 N--CA 1.507 2.396 0 CA-C-O 122.168 0.985 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -164.13 -52.92 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 124.394 1.078 . . . . 0.0 112.639 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.37 152.4 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.092 0 CA-C-O 126.293 2.949 . . . . 0.0 116.452 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 -66.43 1.0 Allowed 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 109.845 -3.343 . . . . 0.0 108.138 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.64 7.98 2.66 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.12 -94.14 0.05 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.715 2.857 . . . . 0.0 118.715 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -98.87 7.26 46.23 Favored 'General case' 0 N--CA 1.496 1.835 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -171.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.74 30.25 4.09 Favored 'General case' 0 N--CA 1.517 2.898 0 CA-C-N 121.355 1.889 . . . . 0.0 109.451 172.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 p 176.54 -39.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 126.986 2.114 . . . . 0.0 112.11 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 63.63 0.57 Allowed Glycine 0 CA--C 1.55 2.231 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t 50.49 56.67 7.59 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 119.398 3.111 . . . . 0.0 119.398 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.91 -54.24 4.34 Favored 'General case' 0 CA--C 1.579 2.086 0 CA-C-N 121.629 2.013 . . . . 0.0 112.431 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 117.89 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 129.872 3.269 . . . . 0.0 107.852 -175.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.699 0 CA-C-O 117.971 -1.461 . . . . 0.0 113.766 174.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -176.61 -8.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.06 138.74 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 CA-C-O 126.081 2.848 . . . . 0.0 116.824 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.17 -35.01 5.76 Favored 'General case' 0 CA--C 1.579 2.073 0 CA-C-N 109.157 -3.656 . . . . 0.0 110.369 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -98.44 20.86 11.98 Favored 'General case' 0 CA--C 1.589 2.462 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.75 -104.91 0.09 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 121.928 2.149 . . . . 0.0 115.287 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -128.07 6.65 5.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -83.73 17.22 2.37 Favored 'General case' 0 CA--C 1.606 3.125 0 O-C-N 120.191 -1.568 . . . . 0.0 111.64 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.54 -42.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 C-N-CA 129.697 3.199 . . . . 0.0 108.698 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.82 50.23 0.36 Allowed Glycine 0 N--CA 1.486 1.997 0 CA-C-N 119.34 0.973 . . . . 0.0 114.712 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t 49.27 36.33 9.2 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 120.651 3.575 . . . . 0.0 120.651 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -4.64 59.2 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 123.475 2.852 . . . . 0.0 114.088 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.81 10.29 0.36 Allowed 'General case' 0 N--CA 1.525 3.294 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.564 0 C-N-CA 127.628 2.537 . . . . 0.0 109.548 178.593 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.81 -11.53 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.33 131.18 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.057 0 CA-C-O 125.918 2.771 . . . . 0.0 116.063 -170.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.43 -57.81 1.99 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 109.762 -3.381 . . . . 0.0 109.875 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.97 -8.12 55.58 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.45 -99.38 0.15 Allowed 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 121.655 3.946 . . . . 0.0 121.655 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -106.28 5.47 29.77 Favored 'General case' 0 N--CA 1.5 2.064 1 N-CA-C 123.525 4.639 . . . . 0.0 123.525 -170.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.5 7.81 18.62 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 122.086 2.221 . . . . 0.0 112.489 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -171.55 -23.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.04 0 C-N-CA 127.983 2.513 . . . . 0.0 111.743 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.9 66.51 0.83 Allowed Glycine 0 N--CA 1.494 2.516 0 CA-C-N 122.85 2.568 . . . . 0.0 109.644 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 m 47.97 32.31 2.79 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -100.15 93.29 5.64 Favored 'General case' 0 CA--C 1.563 1.453 0 O-C-N 119.825 -1.797 . . . . 0.0 107.15 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 67.44 0.22 Allowed 'General case' 0 CA--C 1.573 1.85 0 CA-C-O 124.641 2.162 . . . . 0.0 114.649 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.563 0 CA-C-N 113.288 -1.778 . . . . 0.0 116.177 -179.223 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.59 -8.49 0.14 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.17 130.55 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.322 0 CA-C-O 126.281 2.944 . . . . 0.0 115.782 -172.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -111.91 -54.68 2.59 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 109.923 -3.308 . . . . 0.0 109.024 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -74.16 -7.74 53.69 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.22 -104.22 0.18 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -107.57 4.81 26.38 Favored 'General case' 0 N--CA 1.501 2.102 1 N-CA-C 122.089 4.107 . . . . 0.0 122.089 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -89.5 11.41 19.51 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 121.448 1.931 . . . . 0.0 111.382 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -164.67 -36.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 127.38 2.272 . . . . 0.0 111.34 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.73 63.88 0.6 Allowed Glycine 0 N--CA 1.495 2.574 0 CA-C-N 121.006 1.73 . . . . 0.0 111.952 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 m 39.74 49.25 2.08 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 121.137 3.754 . . . . 0.0 121.137 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.13 -22.79 33.24 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 119.725 -1.86 . . . . 0.0 112.85 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt 54.59 35.22 23.06 Favored 'General case' 0 N--CA 1.52 3.039 0 CA-C-O 124.239 1.971 . . . . 0.0 113.473 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.794 0 C-N-CA 128.18 2.8 . . . . 0.0 110.353 -178.658 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.9 tptm . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.02 -10.12 12.9 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.44 134.72 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.039 0 CA-C-N 124.508 3.322 . . . . 0.0 115.679 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.6 -50.83 2.19 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 127.202 2.201 . . . . 0.0 109.901 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -80.55 -0.31 37.09 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.64 -109.11 0.18 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 118.034 2.605 . . . . 0.0 118.034 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.07 15.46 26.38 Favored 'General case' 0 N--CA 1.497 1.915 1 N-CA-C 121.839 4.014 . . . . 0.0 121.839 -172.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.21 11.08 26.86 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 121.686 2.039 . . . . 0.0 110.889 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -171.51 -29.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 C-N-CA 128.436 2.694 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.87 63.26 0.75 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 121.807 2.094 . . . . 0.0 110.42 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m 42.77 46.68 4.54 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -82.19 -23.97 35.21 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 119.228 -2.17 . . . . 0.0 114.135 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.61 33.89 17.45 Favored 'General case' 0 N--CA 1.523 3.216 0 CA-C-N 121.966 2.166 . . . . 0.0 114.566 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.732 0 C-N-CA 128.143 2.782 . . . . 0.0 108.605 -178.839 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt . . . . . 0 CA--C 1.567 1.614 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -169.1 -10.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.24 126.94 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 125.913 2.768 . . . . 0.0 117.991 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.62 -5.26 32.16 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-N 109.826 -3.352 . . . . 0.0 113.586 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -130.79 18.1 5.16 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.003 2.121 . . . . 0.0 113.647 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.49 -105.54 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 121.254 1.843 . . . . 0.0 115.676 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.99 12.56 4.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -83.63 20.58 1.38 Allowed 'General case' 0 N--CA 1.517 2.881 0 O-C-N 119.424 -2.048 . . . . 0.0 113.611 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p 168.47 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 C-N-CA 131.641 3.976 . . . . 0.0 107.624 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.59 61.79 0.54 Allowed Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.678 1.581 . . . . 0.0 111.209 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t 51.18 25.56 2.48 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -106.12 107.04 17.84 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-N 123.027 2.649 . . . . 0.0 107.272 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -57.35 -32.81 67.11 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 3.086 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 173.559 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 64.9 t80 . . . . . 0 CA--C 1.566 1.593 0 CA-C-O 121.628 0.727 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -84.3 -14.8 48.75 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t 69.42 -51.99 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 C-N-CA 126.678 1.991 . . . . 0.0 112.911 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.1 m170 71.53 -34.19 0.29 Allowed 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.258 1.823 . . . . 0.0 112.894 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 m80 64.43 162.46 0.12 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.592 1.957 . . . . 0.0 116.136 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 44.03 42.24 4.64 Favored 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 129.317 3.047 . . . . 0.0 117.693 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -138.08 -64.68 0.53 Allowed 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.57 0.91 0.3 Allowed 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.3 t -68.27 99.06 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 CA-C-N 123.569 2.895 . . . . 0.0 118.293 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -89.96 -14.15 34.69 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 129.068 2.947 . . . . 0.0 115.057 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -112.26 -1.67 15.09 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.27 -90.3 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -130.07 9.81 5.33 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 121.042 3.719 . . . . 0.0 121.042 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.51 31.93 0.66 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.253 2.297 . . . . 0.0 110.217 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p 158.16 -27.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 C-N-CA 129.599 3.159 . . . . 0.0 109.855 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.23 66.35 0.79 Allowed Glycine 0 N--CA 1.49 2.247 0 CA-C-N 122.68 2.491 . . . . 0.0 109.159 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.9 m 49.12 49.0 20.27 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 118.097 2.628 . . . . 0.0 118.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -174.44 70.77 0.03 OUTLIER 'General case' 0 CA--C 1.577 2.005 0 O-C-N 119.396 -2.065 . . . . 0.0 110.372 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 57.72 4.51 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.721 -1.862 . . . . 0.0 108.665 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.59 51.32 59.41 Favored Glycine 0 CA--C 1.569 3.454 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -171.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.257 . . -147.49 -37.28 0.21 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 121.233 3.79 . . . . 0.0 121.233 -170.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 mp 58.03 36.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.618 3.579 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mt 68.63 90.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 1.992 0 C-N-CA 127.997 2.519 . . . . 0.0 108.531 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 174.69 -91.3 0.08 OUTLIER Glycine 0 N--CA 1.484 1.869 0 O-C-N 121.585 -0.697 . . . . 0.0 112.779 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -143.7 162.58 35.6 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.727 0.775 . . . . 0.0 111.499 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 123.746 1.736 . . . . 0.0 110.9 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.1 t80 . . . . . 0 CA--C 1.564 1.496 0 CA-C-O 121.336 0.589 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -79.38 0.4 Allowed 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 p -149.91 89.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -87.27 66.89 9.4 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 103.198 -2.89 . . . . 0.0 103.198 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -5.21 115.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 119.742 3.238 . . . . 0.0 119.742 -172.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.64 -92.94 0.14 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 115.44 -2.219 . . . . 0.0 109.201 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -165.74 -39.62 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 CA-C-N 123.67 2.941 . . . . 0.0 118.068 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -69.85 -9.27 54.16 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.7 t -56.45 123.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-O 124.013 1.863 . . . . 0.0 115.983 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -115.86 -3.18 12.21 Favored 'General case' 0 CA--C 1.585 2.298 0 C-N-CA 130.748 3.619 . . . . 0.0 113.756 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.78 -3.47 6.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.95 -102.27 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.91 10.19 5.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.41 44.86 1.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 122.503 2.411 . . . . 0.0 108.132 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p 150.68 -33.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 C-N-CA 130.39 3.476 . . . . 0.0 109.311 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 58.81 0.84 Allowed Glycine 0 N--CA 1.49 2.29 0 CA-C-N 121.819 2.1 . . . . 0.0 111.992 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m 54.01 44.42 29.35 Favored 'General case' 0 CA--C 1.59 2.497 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.59 63.27 0.05 Allowed 'General case' 0 CA--C 1.583 2.241 0 O-C-N 119.081 -2.262 . . . . 0.0 113.284 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -83.73 66.28 8.96 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 118.502 -2.624 . . . . 0.0 109.002 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.26 46.51 79.1 Favored Glycine 0 N--CA 1.51 3.633 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -171.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.267 . . -142.51 -52.53 0.4 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 121.33 3.826 . . . . 0.0 121.33 -169.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 mm 61.89 32.92 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.608 3.202 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mt 64.9 81.58 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.075 0 C-N-CA 126.758 2.023 . . . . 0.0 108.498 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.53 -50.72 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 119.072 2.389 . . . . 0.0 119.072 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.2 tp -138.93 120.42 15.01 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 119.239 1.519 . . . . 0.0 110.469 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 124.364 2.031 . . . . 0.0 111.813 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 17.1 t80 . . . . . 0 CA--C 1.566 1.573 0 CA-C-O 121.851 0.834 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -102.58 81.24 2.01 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-O 122.919 1.342 . . . . 0.0 108.38 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 t -58.05 106.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.535 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -86.56 78.77 9.12 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -29.53 133.17 0.05 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 120.892 3.664 . . . . 0.0 120.892 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.435 ' CD ' ' H ' ' A' ' 7' ' ' LYS . 0.9 OUTLIER -158.43 -85.31 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 117.538 -1.22 . . . . 0.0 111.077 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' H ' ' CD ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -169.45 -20.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 tp -65.91 -53.89 33.5 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.984 2.629 . . . . 0.0 117.425 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.3 t -40.28 130.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 126.386 2.993 . . . . 0.0 116.572 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.04 7.59 7.29 Favored 'General case' 0 CA--C 1.584 2.252 1 CA-C-N 107.775 -4.284 . . . . 0.0 114.563 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -128.74 -43.61 1.37 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.81 2.044 . . . . 0.0 113.389 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.54 -95.32 0.23 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 15' ' ' VAL . 4.9 tt0 -136.72 14.61 3.14 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 120.329 3.455 . . . . 0.0 120.329 -174.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -85.23 23.81 1.22 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 122.5 2.409 . . . . 0.0 110.672 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 13' ' ' GLU . 11.6 p 168.05 -27.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 C-N-CA 131.185 3.794 . . . . 0.0 109.445 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.49 70.74 1.14 Allowed Glycine 0 N--CA 1.49 2.295 0 CA-C-N 122.944 2.611 . . . . 0.0 111.11 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m 51.54 39.41 24.7 Favored 'General case' 0 CA--C 1.592 2.592 0 N-CA-C 119.936 3.31 . . . . 0.0 119.936 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -173.78 78.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 118.693 -2.504 . . . . 0.0 111.643 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -104.65 70.43 0.94 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 57.25 52.45 51.45 Favored Glycine 0 N--CA 1.51 3.595 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.253 . . -152.8 -50.96 0.1 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 120.974 3.694 . . . . 0.0 120.974 -170.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mp 58.94 31.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.613 3.378 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.8 mt 62.84 71.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 119.226 -2.171 . . . . 0.0 107.11 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.05 -24.84 0.12 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 121.4 3.32 . . . . 0.0 121.4 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.3 -87.3 0.47 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 121.802 2.801 . . . . 0.0 105.801 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 123.682 1.706 . . . . 0.0 108.295 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 CA--C 1.57 1.718 0 CA-C-O 117.722 -1.132 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -150.5 -56.83 0.17 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 121.3 1.864 . . . . 0.0 112.839 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.7 m -41.75 121.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 123.661 1.696 . . . . 0.0 114.667 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -121.25 90.85 3.4 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 91.46 170.22 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 129.75 3.22 . . . . 0.0 109.655 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 122.52 -73.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 128.953 2.901 . . . . 0.0 106.424 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -153.99 -46.68 0.09 Allowed 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -97.96 3.07 49.61 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 119.037 2.977 . . . . 0.0 119.037 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 12' ' ' ALA . 3.7 t -72.72 94.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 N-CA-C 120.081 3.363 . . . . 0.0 120.081 -169.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -81.32 -23.08 38.05 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 128.648 2.779 . . . . 0.0 114.666 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -100.65 -16.91 17.26 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.402 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -139.72 -82.91 0.26 Allowed 'General case' 0 CA--C 1.555 1.158 1 N-CA-C 123.12 4.489 . . . . 0.0 123.12 -172.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 15' ' ' VAL . 11.9 tt0 -127.23 -1.12 6.39 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.481 3.882 . . . . 0.0 121.481 -171.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.21 25.98 0.22 Allowed 'General case' 0 N--CA 1.521 3.109 0 CA-C-N 123.086 2.676 . . . . 0.0 111.898 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 13' ' ' GLU . 3.7 p 164.91 -27.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.033 0 C-N-CA 129.642 3.177 . . . . 0.0 110.643 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.93 68.66 0.77 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 122.459 2.39 . . . . 0.0 108.074 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.1 m 46.03 45.78 12.39 Favored 'General case' 0 CA--C 1.593 2.612 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -171.39 72.34 0.05 OUTLIER 'General case' 0 CA--C 1.577 2.018 0 O-C-N 119.39 -2.069 . . . . 0.0 110.36 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.9 58.02 4.83 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 119.953 -1.717 . . . . 0.0 109.068 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.25 54.64 36.25 Favored Glycine 0 N--CA 1.51 3.608 0 N-CA-C 105.968 -2.853 . . . . 0.0 105.968 -170.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.266 . . -147.51 -39.54 0.19 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 121.762 3.986 . . . . 0.0 121.762 -169.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mm 61.79 26.16 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.614 3.425 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -172.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mt 69.72 81.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 C-N-CA 127.449 2.3 . . . . 0.0 107.723 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.08 -56.68 0.44 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 115.713 1.045 . . . . 0.0 115.713 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.8 mt -87.92 179.47 6.44 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 117.833 0.816 . . . . 0.0 111.986 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 123.996 1.855 . . . . 0.0 108.808 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 21.5 t80 . . . . . 0 CA--C 1.563 1.456 0 CA-C-O 121.309 0.576 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.38 -41.82 6.88 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.5 m -77.79 87.43 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 123.031 1.396 . . . . 0.0 110.966 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -84.63 74.99 10.34 Favored 'General case' 0 CA--C 1.581 2.147 0 O-C-N 120.008 -1.683 . . . . 0.0 109.936 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.8 m80 1.07 132.64 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.118 1 N-CA-C 123.752 4.723 . . . . 0.0 123.752 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 67.82 68.41 0.35 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 129.167 2.987 . . . . 0.0 111.477 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.01 -53.43 1.74 Allowed 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 113.291 -1.777 . . . . 0.0 112.411 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -173.36 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 125.302 1.441 . . . . 0.0 111.817 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -16.25 101.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.589 2.453 0 C-N-CA 130.685 3.594 . . . . 0.0 118.067 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -100.45 -4.01 29.75 Favored 'General case' 0 CA--C 1.585 2.292 1 CA-C-N 107.562 -4.381 . . . . 0.0 114.01 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -119.8 -8.8 9.82 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 127.559 2.344 . . . . 0.0 116.133 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.94 -86.36 0.11 Allowed 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 119.412 3.115 . . . . 0.0 119.412 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -125.49 4.32 7.63 Favored 'General case' 0 N--CA 1.498 1.937 1 N-CA-C 122.591 4.293 . . . . 0.0 122.591 -172.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.81 9.11 4.48 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 121.77 2.077 . . . . 0.0 112.737 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p 176.51 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 C-N-CA 129.737 3.215 . . . . 0.0 111.335 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.68 58.73 0.89 Allowed Glycine 0 N--CA 1.494 2.529 0 CA-C-N 122.869 2.577 . . . . 0.0 109.789 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p 52.63 50.6 17.81 Favored 'General case' 0 CA--C 1.589 2.468 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -173.7 68.82 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.902 0 O-C-N 119.566 -1.959 . . . . 0.0 110.384 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.76 59.99 3.34 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.802 -1.811 . . . . 0.0 108.463 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.2 57.41 15.54 Favored Glycine 0 N--CA 1.503 3.151 0 N-CA-C 106.368 -2.693 . . . . 0.0 106.368 -172.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.22 -41.17 0.09 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 120.586 3.55 . . . . 0.0 120.586 -171.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.8 mm 60.03 29.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.613 3.378 0 CA-C-N 119.622 1.101 . . . . 0.0 108.263 -172.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 mt 70.0 86.24 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 C-N-CA 127.389 2.275 . . . . 0.0 107.861 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.51 -81.29 0.07 OUTLIER Glycine 0 N--CA 1.485 1.933 0 O-C-N 121.262 -0.899 . . . . 0.0 114.68 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 pp -136.92 164.05 29.23 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.169 0.985 . . . . 0.0 112.271 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 35.2 mmt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 123.505 1.621 . . . . 0.0 110.154 179.445 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 CA--C 1.562 1.433 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.82 78.02 1.77 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.306 1.051 . . . . 0.0 108.519 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -86.05 114.2 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.87 -1.144 . . . . 0.0 108.288 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -66.12 -20.34 66.12 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.4 m80 61.13 165.62 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.453 2.019 . . . . 0.0 116.453 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 42.47 42.28 2.64 Favored 'General case' 0 CA--C 1.577 2.014 0 C-N-CA 129.283 3.033 . . . . 0.0 118.268 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -138.05 -61.94 0.6 Allowed 'General case' 0 CA--C 1.567 1.61 0 O-C-N 121.078 -1.014 . . . . 0.0 113.223 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.54 -43.47 0.19 Allowed 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 t -25.48 105.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.591 2.537 0 CA-C-O 127.292 3.425 . . . . 0.0 116.77 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -106.41 7.06 30.91 Favored 'General case' 0 CA--C 1.577 2.001 2 CA-C-N 107.077 -4.601 . . . . 0.0 114.658 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -130.6 -57.39 1.06 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 125.933 1.693 . . . . 0.0 113.12 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.08 -80.62 0.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' VAL . 2.5 tt0 -149.12 12.93 0.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 120.966 3.691 . . . . 0.0 120.966 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -85.68 39.09 0.78 Allowed 'General case' 0 N--CA 1.516 2.83 0 CA-C-N 122.543 2.429 . . . . 0.0 108.671 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLU . 4.3 p 152.43 -28.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.091 0 C-N-CA 130.63 3.572 . . . . 0.0 109.021 -174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.16 55.43 3.1 Favored Glycine 0 N--CA 1.491 2.365 0 CA-C-N 122.685 2.493 . . . . 0.0 109.596 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m 63.6 95.38 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.155 1.382 . . . . 0.0 112.648 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 149.52 47.77 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.139 0 C-N-CA 127.4 2.28 . . . . 0.0 111.239 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 63.4 3.22 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 117.206 -3.434 . . . . 0.0 103.737 175.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.15 -57.22 4.79 Favored Glycine 1 CA--C 1.58 4.103 0 N-CA-C 105.524 -3.03 . . . . 0.0 105.524 -169.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.31 117.31 25.03 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.84 2.856 . . . . 0.0 115.234 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.52 65.61 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.225 0 N-CA-C 102.764 -3.05 . . . . 0.0 102.764 172.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.2 mt 71.25 86.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.581 2.136 0 C-N-CA 126.526 1.931 . . . . 0.0 106.825 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -177.51 -103.33 0.17 Allowed Glycine 0 N--CA 1.487 2.05 0 O-C-N 121.098 -1.001 . . . . 0.0 115.44 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -141.17 149.84 41.98 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.652 1.215 . . . . 0.0 112.281 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 124.869 2.271 . . . . 0.0 112.65 -179.46 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 38.8 t80 . . . . . 0 CA--C 1.567 1.632 0 CA-C-O 121.812 0.815 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.88 -32.55 72.28 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t 70.54 -50.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 C-N-CA 126.09 1.756 . . . . 0.0 111.717 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 70.36 -34.61 0.3 Allowed 'General case' 0 N--CA 1.515 2.799 0 CA-C-N 121.42 1.918 . . . . 0.0 113.318 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.3 m80 70.3 148.19 0.07 Allowed 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 127.795 2.438 . . . . 0.0 116.472 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 64.81 72.79 0.43 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 129.626 3.17 . . . . 0.0 113.322 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -157.78 -88.19 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.899 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.708 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 pp -142.9 1.69 1.3 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 119.201 3.038 . . . . 0.0 119.201 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.1 t -57.58 99.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.249 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 -172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.41 ' HA ' ' H ' ' A' ' 19' ' ' LYS . 23.2 p90 -91.58 -0.17 57.56 Favored 'General case' 0 CA--C 1.58 2.123 0 C-N-CA 128.979 2.912 . . . . 0.0 115.123 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -122.7 -36.01 2.97 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.66 -99.93 0.4 Allowed 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 119.997 3.332 . . . . 0.0 119.997 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 15' ' ' VAL . 1.2 tm-20 -132.49 14.42 4.51 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 -173.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -82.81 20.28 1.19 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 122.288 2.313 . . . . 0.0 112.421 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' A' ' 13' ' ' GLU . 6.0 p 169.13 -24.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.035 0 C-N-CA 130.314 3.446 . . . . 0.0 109.581 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.92 69.55 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-N 123.012 2.642 . . . . 0.0 109.339 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 m 50.51 46.24 25.66 Favored 'General case' 0 CA--C 1.595 2.677 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -174.11 72.42 0.03 OUTLIER 'General case' 0 CA--C 1.581 2.162 0 O-C-N 118.797 -2.44 . . . . 0.0 111.01 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 10' ' ' PHE . 2.4 tpmt? -88.52 65.08 7.73 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 119.509 -1.995 . . . . 0.0 108.581 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 57.7 45.12 93.72 Favored Glycine 0 N--CA 1.511 3.686 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.61 -39.99 0.71 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 120.659 3.578 . . . . 0.0 120.659 -171.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 mp 75.0 -48.64 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.599 2.85 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 -173.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.0 tp 176.07 97.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.29 -42.44 1.42 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 121.368 3.307 . . . . 0.0 121.368 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.05 90.07 2.47 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 118.957 1.379 . . . . 0.0 113.511 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.403 ' HE3' ' HB3' ' A' ' 19' ' ' LYS . 15.1 mmt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 124.79 2.233 . . . . 0.0 112.582 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 85.9 t80 . . . . . 0 CA--C 1.565 1.55 0 CA-C-O 121.025 0.44 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -151.91 90.33 1.53 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.59 119.22 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 119.932 -1.73 . . . . 0.0 107.218 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -83.92 72.07 10.45 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -98.01 149.11 22.8 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 125.544 1.538 . . . . 0.0 113.861 -175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.18 -54.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.417 1.087 . . . . 0.0 108.571 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.54 72.59 0.09 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 123.318 1.533 . . . . 0.0 108.622 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tp -159.32 -56.55 0.06 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.822 -1.174 . . . . 0.0 111.368 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG11 ' H ' ' A' ' 12' ' ' ALA . 42.5 t -51.13 103.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 126.864 3.221 . . . . 0.0 117.405 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -88.56 -9.5 52.06 Favored 'General case' 0 CA--C 1.577 2.007 0 CA-C-N 108.546 -3.934 . . . . 0.0 114.811 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -115.46 -14.89 11.54 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 127.191 2.196 . . . . 0.0 116.227 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.473 ' H ' HG11 ' A' ' 9' ' ' VAL . . . -147.64 -70.5 0.23 Allowed 'General case' 0 CA--C 1.562 1.44 1 N-CA-C 124.291 4.923 . . . . 0.0 124.291 -174.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 15' ' ' VAL . 4.8 mt-10 -129.52 -17.56 3.68 Favored 'General case' 0 N--CA 1.504 2.241 1 N-CA-C 126.967 5.914 . . . . 0.0 126.967 -170.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.2 27.7 0.67 Allowed 'General case' 0 N--CA 1.52 3.055 0 CA-C-N 123.806 3.003 . . . . 0.0 111.549 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 13' ' ' GLU . 8.4 p 176.45 -32.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 C-N-CA 128.902 2.881 . . . . 0.0 110.66 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.92 65.18 0.79 Allowed Glycine 0 N--CA 1.489 2.17 0 CA-C-N 121.766 2.076 . . . . 0.0 110.558 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m 50.91 45.9 26.94 Favored 'General case' 0 CA--C 1.586 2.354 0 N-CA-C 117.884 2.55 . . . . 0.0 117.884 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -173.17 74.14 0.04 OUTLIER 'General case' 0 CA--C 1.576 1.949 0 O-C-N 119.669 -1.894 . . . . 0.0 111.094 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.71 62.78 3.29 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 119.942 -1.724 . . . . 0.0 107.454 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.85 51.89 56.44 Favored Glycine 0 N--CA 1.508 3.477 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.253 . . -147.7 -42.74 0.17 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 120.614 3.561 . . . . 0.0 120.614 -170.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.1 mp 57.86 35.99 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.614 3.42 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt 66.93 83.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 C-N-CA 127.337 2.255 . . . . 0.0 109.223 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.01 -65.57 0.3 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 118.163 2.025 . . . . 0.0 118.163 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 pp -102.62 -177.36 3.36 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 9.7 mmt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 123.865 1.793 . . . . 0.0 108.015 179.725 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 37.1 t80 . . . . . 0 CA--C 1.565 1.542 0 CA-C-O 121.603 0.716 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -65.93 -31.15 71.91 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 t 71.86 89.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 126.363 1.865 . . . . 0.0 107.401 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -84.53 74.15 10.44 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -34.21 117.28 0.33 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 119.994 3.331 . . . . 0.0 119.994 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.5 1.8 0.03 OUTLIER 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 117.997 2.592 . . . . 0.0 117.997 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt 84.92 87.05 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 127.286 2.234 . . . . 0.0 107.947 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.85 -52.64 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.069 0.948 . . . . 0.0 112.38 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 t -53.44 148.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 CA-C-O 124.674 2.178 . . . . 0.0 115.682 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 -51.15 2.21 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 111.215 -2.721 . . . . 0.0 109.725 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -91.72 10.41 28.46 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.32 -109.52 0.17 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 123.696 2.953 . . . . 0.0 116.688 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -125.88 17.53 7.96 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.89 1.66 55.33 Favored 'General case' 0 CA--C 1.599 2.843 0 O-C-N 119.82 -1.8 . . . . 0.0 110.351 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 m -151.48 -40.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.904 0 C-N-CA 129.301 3.04 . . . . 0.0 110.085 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.85 62.31 0.56 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.93 1.241 . . . . 0.0 114.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.5 t 35.54 45.84 0.26 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 119.612 3.19 . . . . 0.0 119.612 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -101.65 -1.58 32.36 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.3 pttt 67.44 -49.99 0.5 Allowed 'General case' 0 N--CA 1.515 2.81 0 C-N-CA 128.059 2.544 . . . . 0.0 112.032 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.48 -10.93 39.98 Favored Glycine 0 CA--C 1.56 2.883 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.6 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.41 77.48 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.155 1.782 . . . . 0.0 114.385 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.8 mt -82.65 50.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.595 2.708 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.35 -61.65 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 O-C-N 120.554 -1.341 . . . . 0.0 108.097 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.03 67.06 0.05 OUTLIER Glycine 0 N--CA 1.485 1.936 0 CA-C-N 119.502 1.046 . . . . 0.0 112.984 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -153.07 -80.6 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.076 0.938 . . . . 0.0 110.037 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-N 119.897 1.226 . . . . 0.0 113.601 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 39.3 t80 . . . . . 0 CA--C 1.567 1.614 0 CA-C-O 122.37 1.081 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.91 92.4 2.6 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.81 120.88 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 O-C-N 120.939 -1.101 . . . . 0.0 110.387 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.8 103.95 15.91 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.454 ' CG ' ' H ' ' A' ' 6' ' ' GLN . 6.6 p80 -131.08 -67.81 0.69 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.033 0.933 . . . . 0.0 109.718 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' A' ' 5' ' ' HIS . 0.9 OUTLIER 54.78 62.14 2.66 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 127.716 2.406 . . . . 0.0 113.281 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 93.03 81.75 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 126.915 2.086 . . . . 0.0 111.274 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -164.13 -52.92 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 124.394 1.078 . . . . 0.0 112.639 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.37 152.4 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.092 0 CA-C-O 126.293 2.949 . . . . 0.0 116.452 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 -66.43 1.0 Allowed 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 109.845 -3.343 . . . . 0.0 108.138 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.64 7.98 2.66 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.12 -94.14 0.05 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.715 2.857 . . . . 0.0 118.715 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -98.87 7.26 46.23 Favored 'General case' 0 N--CA 1.496 1.835 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -171.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.74 30.25 4.09 Favored 'General case' 0 N--CA 1.517 2.898 0 CA-C-N 121.355 1.889 . . . . 0.0 109.451 172.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 p 176.54 -39.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 126.986 2.114 . . . . 0.0 112.11 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 63.63 0.57 Allowed Glycine 0 CA--C 1.55 2.231 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t 50.49 56.67 7.59 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 119.398 3.111 . . . . 0.0 119.398 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.91 -54.24 4.34 Favored 'General case' 0 CA--C 1.579 2.086 0 CA-C-N 121.629 2.013 . . . . 0.0 112.431 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 117.89 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 129.872 3.269 . . . . 0.0 107.852 -175.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.03 -17.74 7.67 Favored Glycine 0 CA--C 1.557 2.699 0 CA-C-O 117.971 -1.461 . . . . 0.0 113.766 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.44 78.05 0.23 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 120.57 2.185 . . . . 0.0 111.303 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -80.9 63.62 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.372 0 CA-C-O 124.222 1.963 . . . . 0.0 105.903 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.3 mm -127.6 -58.18 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 C-N-CA 126.936 2.094 . . . . 0.0 105.73 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 167.04 58.78 0.03 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.79 -140.65 0.05 OUTLIER 'General case' 0 CA--C 1.582 2.18 0 CA-C-N 118.028 0.914 . . . . 0.0 108.78 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.981 0 O-C-N 118.577 -2.577 . . . . 0.0 115.24 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 17.3 p90 . . . . . 0 CA--C 1.566 1.572 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -148.83 -109.45 0.07 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.9 t 62.45 -41.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 67.14 82.6 0.18 Allowed 'General case' 0 N--CA 1.512 2.652 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -55.4 149.09 13.81 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 121.198 3.777 . . . . 0.0 121.198 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 65.38 75.27 0.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 110.385 -3.098 . . . . 0.0 113.025 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.65 -50.32 0.98 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.155 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -176.61 -8.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.06 138.74 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 CA-C-O 126.081 2.848 . . . . 0.0 116.824 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.17 -35.01 5.76 Favored 'General case' 0 CA--C 1.579 2.073 0 CA-C-N 109.157 -3.656 . . . . 0.0 110.369 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -98.44 20.86 11.98 Favored 'General case' 0 CA--C 1.589 2.462 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.75 -104.91 0.09 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 121.928 2.149 . . . . 0.0 115.287 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -128.07 6.65 5.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -83.73 17.22 2.37 Favored 'General case' 0 CA--C 1.606 3.125 0 O-C-N 120.191 -1.568 . . . . 0.0 111.64 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.54 -42.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 C-N-CA 129.697 3.199 . . . . 0.0 108.698 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.82 50.23 0.36 Allowed Glycine 0 N--CA 1.486 1.997 0 CA-C-N 119.34 0.973 . . . . 0.0 114.712 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t 49.27 36.33 9.2 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 120.651 3.575 . . . . 0.0 120.651 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -4.64 59.2 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 123.475 2.852 . . . . 0.0 114.088 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.81 10.29 0.36 Allowed 'General case' 0 N--CA 1.525 3.294 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.95 -47.29 0.05 OUTLIER Glycine 0 CA--C 1.555 2.564 0 C-N-CA 127.628 2.537 . . . . 0.0 109.548 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 77.09 88.37 0.08 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.319 2.248 . . . . 0.0 113.907 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.8 mp -68.76 -34.23 63.62 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.537 0 CA-C-N 110.123 -3.217 . . . . 0.0 107.26 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.94 73.83 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.911 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.65 -50.0 0.25 Allowed Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.196 -0.94 . . . . 0.0 114.761 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 tm? 61.85 87.04 0.1 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 126.245 1.818 . . . . 0.0 112.99 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 122.865 1.317 . . . . 0.0 109.883 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 CA--C 1.578 2.051 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -87.85 -69.84 0.67 Allowed 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 119.91 1.232 . . . . 0.0 112.557 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.3 m -91.62 108.96 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 122.618 1.199 . . . . 0.0 110.755 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -92.79 53.34 2.01 Favored 'General case' 0 CA--C 1.579 2.079 0 O-C-N 120.823 -1.173 . . . . 0.0 110.011 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 18.13 94.88 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 119.84 3.274 . . . . 0.0 119.84 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.34 -75.08 0.6 Allowed 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.26 80.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.741 1.216 . . . . 0.0 107.768 177.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.81 -11.53 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.33 131.18 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.057 0 CA-C-O 125.918 2.771 . . . . 0.0 116.063 -170.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.43 -57.81 1.99 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 109.762 -3.381 . . . . 0.0 109.875 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.97 -8.12 55.58 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.45 -99.38 0.15 Allowed 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 121.655 3.946 . . . . 0.0 121.655 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -106.28 5.47 29.77 Favored 'General case' 0 N--CA 1.5 2.064 1 N-CA-C 123.525 4.639 . . . . 0.0 123.525 -170.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.5 7.81 18.62 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 122.086 2.221 . . . . 0.0 112.489 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -171.55 -23.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.04 0 C-N-CA 127.983 2.513 . . . . 0.0 111.743 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.9 66.51 0.83 Allowed Glycine 0 N--CA 1.494 2.516 0 CA-C-N 122.85 2.568 . . . . 0.0 109.644 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 m 47.97 32.31 2.79 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -100.15 93.29 5.64 Favored 'General case' 0 CA--C 1.563 1.453 0 O-C-N 119.825 -1.797 . . . . 0.0 107.15 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 67.44 0.22 Allowed 'General case' 0 CA--C 1.573 1.85 0 CA-C-O 124.641 2.162 . . . . 0.0 114.649 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.51 10.33 0.08 OUTLIER Glycine 0 CA--C 1.555 2.563 0 CA-C-N 113.288 -1.778 . . . . 0.0 116.177 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.82 -101.51 0.42 Allowed 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.1 mt 70.84 -76.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 tp -133.72 -13.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.311 0 C-N-CA 125.054 1.341 . . . . 0.0 112.319 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.11 65.51 0.47 Allowed Glycine 0 N--CA 1.49 2.27 0 CA-C-N 121.48 1.946 . . . . 0.0 113.498 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -150.35 -58.08 0.18 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.616 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -179.024 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 55.8 t80 . . . . . 0 CA--C 1.563 1.457 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -113.15 43.69 1.67 Allowed 'General case' 0 CA--C 1.581 2.173 0 CA-C-O 121.268 0.556 . . . . 0.0 111.827 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.22 104.27 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 119.783 -1.823 . . . . 0.0 108.46 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -91.25 74.79 6.17 Favored 'General case' 0 CA--C 1.577 2.007 0 CA-C-O 122.469 1.128 . . . . 0.0 108.081 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -27.11 145.06 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 121.67 3.952 . . . . 0.0 121.67 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 64.11 72.09 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 127.721 2.408 . . . . 0.0 108.86 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.6 -62.17 0.66 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.988 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.59 -8.49 0.14 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.17 130.55 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.322 0 CA-C-O 126.281 2.944 . . . . 0.0 115.782 -172.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -111.91 -54.68 2.59 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 109.923 -3.308 . . . . 0.0 109.024 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -74.16 -7.74 53.69 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.22 -104.22 0.18 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -107.57 4.81 26.38 Favored 'General case' 0 N--CA 1.501 2.102 1 N-CA-C 122.089 4.107 . . . . 0.0 122.089 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -89.5 11.41 19.51 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 121.448 1.931 . . . . 0.0 111.382 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -164.67 -36.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 127.38 2.272 . . . . 0.0 111.34 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.73 63.88 0.6 Allowed Glycine 0 N--CA 1.495 2.574 0 CA-C-N 121.006 1.73 . . . . 0.0 111.952 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 m 39.74 49.25 2.08 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 121.137 3.754 . . . . 0.0 121.137 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.13 -22.79 33.24 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 119.725 -1.86 . . . . 0.0 112.85 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt 54.59 35.22 23.06 Favored 'General case' 0 N--CA 1.52 3.039 0 CA-C-O 124.239 1.971 . . . . 0.0 113.473 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.45 -39.83 0.08 OUTLIER Glycine 0 CA--C 1.559 2.794 0 C-N-CA 128.18 2.8 . . . . 0.0 110.353 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 67.88 83.52 0.16 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 126.529 1.932 . . . . 0.0 111.504 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.52 53.09 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.592 2.596 0 CA-C-N 112.83 -1.986 . . . . 0.0 105.738 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tp -119.35 -51.6 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 C-N-CA 125.194 1.398 . . . . 0.0 109.045 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.53 57.86 0.02 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 115.453 0.941 . . . . 0.0 115.453 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.31 -67.54 0.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 118.749 1.275 . . . . 0.0 109.915 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.5 mpp? . . . . . 0 N--CA 1.494 1.757 0 CA-C-N 120.761 1.619 . . . . 0.0 111.244 -179.558 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 56.8 t80 . . . . . 0 CA--C 1.565 1.526 0 CA-C-O 121.199 0.523 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -142.87 90.44 2.21 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 123.281 1.515 . . . . 0.0 107.347 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -67.68 -36.29 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 m170 72.79 -50.14 0.7 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-N 121.898 2.136 . . . . 0.0 111.807 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 71.92 132.34 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.757 0 C-N-CA 127.296 2.239 . . . . 0.0 114.556 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 68.33 57.4 0.46 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 128.502 2.721 . . . . 0.0 113.568 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -179.56 -62.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 123.76 0.824 . . . . 0.0 112.284 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.02 -10.12 12.9 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.44 134.72 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.039 0 CA-C-N 124.508 3.322 . . . . 0.0 115.679 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.6 -50.83 2.19 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 127.202 2.201 . . . . 0.0 109.901 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -80.55 -0.31 37.09 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.64 -109.11 0.18 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 118.034 2.605 . . . . 0.0 118.034 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.07 15.46 26.38 Favored 'General case' 0 N--CA 1.497 1.915 1 N-CA-C 121.839 4.014 . . . . 0.0 121.839 -172.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.21 11.08 26.86 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 121.686 2.039 . . . . 0.0 110.889 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -171.51 -29.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 C-N-CA 128.436 2.694 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.87 63.26 0.75 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 121.807 2.094 . . . . 0.0 110.42 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m 42.77 46.68 4.54 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -82.19 -23.97 35.21 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 119.228 -2.17 . . . . 0.0 114.135 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.61 33.89 17.45 Favored 'General case' 0 N--CA 1.523 3.216 0 CA-C-N 121.966 2.166 . . . . 0.0 114.566 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.29 -47.7 0.05 OUTLIER Glycine 0 CA--C 1.558 2.732 0 C-N-CA 128.143 2.782 . . . . 0.0 108.605 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 74.59 87.13 0.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 127.496 2.318 . . . . 0.0 114.539 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.6 -43.97 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.427 0 CA-C-N 112.197 -2.274 . . . . 0.0 105.342 173.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.93 74.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.083 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 167.02 -137.43 4.63 Favored Glycine 0 CA--C 1.546 1.974 0 O-C-N 121.172 -0.955 . . . . 0.0 113.195 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -157.5 -37.87 0.07 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.569 1.682 0 CA-C-O 125.01 2.338 . . . . 0.0 114.596 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 40.5 t80 . . . . . 0 CA--C 1.563 1.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.06 98.4 2.57 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 m -105.03 -54.64 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.077 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 61.64 3.78 0.92 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 121.121 1.782 . . . . 0.0 115.299 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 m170 67.19 117.01 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 128.977 2.911 . . . . 0.0 114.673 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.24 54.2 3.31 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 111.782 -2.463 . . . . 0.0 113.325 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -97.31 -59.98 1.67 Allowed 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -169.1 -10.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.24 126.94 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 125.913 2.768 . . . . 0.0 117.991 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.62 -5.26 32.16 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-N 109.826 -3.352 . . . . 0.0 113.586 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -130.79 18.1 5.16 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.003 2.121 . . . . 0.0 113.647 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.49 -105.54 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 121.254 1.843 . . . . 0.0 115.676 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.99 12.56 4.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -83.63 20.58 1.38 Allowed 'General case' 0 N--CA 1.517 2.881 0 O-C-N 119.424 -2.048 . . . . 0.0 113.611 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p 168.47 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 C-N-CA 131.641 3.976 . . . . 0.0 107.624 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.59 61.79 0.54 Allowed Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.678 1.581 . . . . 0.0 111.209 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t 51.18 25.56 2.48 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -106.12 107.04 17.84 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-N 123.027 2.649 . . . . 0.0 107.272 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -57.35 -32.81 67.11 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.42 -45.86 44.51 Favored Glycine 0 CA--C 1.563 3.086 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 71.11 106.08 0.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.492 2.317 . . . . 0.0 116.624 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.77 -38.12 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.389 0 CA-C-N 111.879 -2.419 . . . . 0.0 106.519 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mt -124.62 76.21 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.978 0 CA-C-N 119.84 1.2 . . . . 0.0 108.942 177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.91 58.37 0.05 OUTLIER Glycine 0 N--CA 1.493 2.466 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.485 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -45.14 121.59 2.94 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 122.052 0.93 . . . . 0.0 110.804 -179.377 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt . . . . . 0 CA--C 1.567 1.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.57 0.91 0.3 Allowed 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 12' ' ' ALA . 12.3 t -68.27 99.06 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 CA-C-N 123.569 2.895 . . . . 0.0 118.293 -171.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -89.96 -14.15 34.69 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 129.068 2.947 . . . . 0.0 115.057 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -112.26 -1.67 15.09 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -149.27 -90.3 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -130.07 9.81 5.33 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 121.042 3.719 . . . . 0.0 121.042 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.51 31.93 0.66 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.253 2.297 . . . . 0.0 110.217 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p 158.16 -27.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 C-N-CA 129.599 3.159 . . . . 0.0 109.855 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.23 66.35 0.79 Allowed Glycine 0 N--CA 1.49 2.247 0 CA-C-N 122.68 2.491 . . . . 0.0 109.159 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.9 m 49.12 49.0 20.27 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 118.097 2.628 . . . . 0.0 118.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -174.44 70.77 0.03 OUTLIER 'General case' 0 CA--C 1.577 2.005 0 O-C-N 119.396 -2.065 . . . . 0.0 110.372 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 57.72 4.51 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.721 -1.862 . . . . 0.0 108.665 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 3.454 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -171.003 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.512 2.653 0 N-CA-C 118.068 2.618 . . . . 0.0 118.068 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -69.85 -9.27 54.16 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 12' ' ' ALA . 41.7 t -56.45 123.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-O 124.013 1.863 . . . . 0.0 115.983 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -115.86 -3.18 12.21 Favored 'General case' 0 CA--C 1.585 2.298 0 C-N-CA 130.748 3.619 . . . . 0.0 113.756 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.78 -3.47 6.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -176.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -141.95 -102.27 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.91 10.19 5.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.41 44.86 1.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 122.503 2.411 . . . . 0.0 108.132 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p 150.68 -33.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 C-N-CA 130.39 3.476 . . . . 0.0 109.311 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 58.81 0.84 Allowed Glycine 0 N--CA 1.49 2.29 0 CA-C-N 121.819 2.1 . . . . 0.0 111.992 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m 54.01 44.42 29.35 Favored 'General case' 0 CA--C 1.59 2.497 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.59 63.27 0.05 Allowed 'General case' 0 CA--C 1.583 2.241 0 O-C-N 119.081 -2.262 . . . . 0.0 113.284 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -83.73 66.28 8.96 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 118.502 -2.624 . . . . 0.0 109.002 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.633 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -171.433 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 tp -65.91 -53.89 33.5 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.984 2.629 . . . . 0.0 117.425 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 12' ' ' ALA . 39.3 t -40.28 130.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 126.386 2.993 . . . . 0.0 116.572 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.04 7.59 7.29 Favored 'General case' 0 CA--C 1.584 2.252 1 CA-C-N 107.775 -4.284 . . . . 0.0 114.563 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -128.74 -43.61 1.37 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.81 2.044 . . . . 0.0 113.389 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -98.54 -95.32 0.23 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -136.72 14.61 3.14 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 120.329 3.455 . . . . 0.0 120.329 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.415 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 1.8 m-20 -85.23 23.81 1.22 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 122.5 2.409 . . . . 0.0 110.672 173.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 p 168.05 -27.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 C-N-CA 131.185 3.794 . . . . 0.0 109.445 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.49 70.74 1.14 Allowed Glycine 0 N--CA 1.49 2.295 0 CA-C-N 122.944 2.611 . . . . 0.0 111.11 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m 51.54 39.41 24.7 Favored 'General case' 0 CA--C 1.592 2.592 0 N-CA-C 119.936 3.31 . . . . 0.0 119.936 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -173.78 78.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 118.693 -2.504 . . . . 0.0 111.643 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -104.65 70.43 0.94 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.595 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 pttm . . . . . 0 N--CA 1.513 2.678 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -97.96 3.07 49.61 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 119.037 2.977 . . . . 0.0 119.037 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 12' ' ' ALA . 3.7 t -72.72 94.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 N-CA-C 120.081 3.363 . . . . 0.0 120.081 -169.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -81.32 -23.08 38.05 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 128.648 2.779 . . . . 0.0 114.666 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -100.65 -16.91 17.26 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -139.72 -82.91 0.26 Allowed 'General case' 0 CA--C 1.555 1.158 1 N-CA-C 123.12 4.489 . . . . 0.0 123.12 -172.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -127.23 -1.12 6.39 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.481 3.882 . . . . 0.0 121.481 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.21 25.98 0.22 Allowed 'General case' 0 N--CA 1.521 3.109 0 CA-C-N 123.086 2.676 . . . . 0.0 111.898 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 p 164.91 -27.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.033 0 C-N-CA 129.642 3.177 . . . . 0.0 110.643 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.93 68.66 0.77 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 122.459 2.39 . . . . 0.0 108.074 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.1 m 46.03 45.78 12.39 Favored 'General case' 0 CA--C 1.593 2.612 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -171.39 72.34 0.05 OUTLIER 'General case' 0 CA--C 1.577 2.018 0 O-C-N 119.39 -2.069 . . . . 0.0 110.36 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.9 58.02 4.83 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 119.953 -1.717 . . . . 0.0 109.068 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.608 0 N-CA-C 105.968 -2.853 . . . . 0.0 105.968 -170.958 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.566 1.585 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -173.36 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 125.302 1.441 . . . . 0.0 111.817 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -16.25 101.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.589 2.453 0 C-N-CA 130.685 3.594 . . . . 0.0 118.067 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -100.45 -4.01 29.75 Favored 'General case' 0 CA--C 1.585 2.292 1 CA-C-N 107.562 -4.381 . . . . 0.0 114.01 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -119.8 -8.8 9.82 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 127.559 2.344 . . . . 0.0 116.133 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.94 -86.36 0.11 Allowed 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 119.412 3.115 . . . . 0.0 119.412 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -125.49 4.32 7.63 Favored 'General case' 0 N--CA 1.498 1.937 1 N-CA-C 122.591 4.293 . . . . 0.0 122.591 -172.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.81 9.11 4.48 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 121.77 2.077 . . . . 0.0 112.737 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p 176.51 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 C-N-CA 129.737 3.215 . . . . 0.0 111.335 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.68 58.73 0.89 Allowed Glycine 0 N--CA 1.494 2.529 0 CA-C-N 122.869 2.577 . . . . 0.0 109.789 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p 52.63 50.6 17.81 Favored 'General case' 0 CA--C 1.589 2.468 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -173.7 68.82 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.902 0 O-C-N 119.566 -1.959 . . . . 0.0 110.384 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.76 59.99 3.34 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.802 -1.811 . . . . 0.0 108.463 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.151 0 N-CA-C 106.368 -2.693 . . . . 0.0 106.368 -172.688 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.0 tttp . . . . . 0 CA--C 1.567 1.61 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.54 -43.47 0.19 Allowed 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 t -25.48 105.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.591 2.537 0 CA-C-O 127.292 3.425 . . . . 0.0 116.77 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -106.41 7.06 30.91 Favored 'General case' 0 CA--C 1.577 2.001 2 CA-C-N 107.077 -4.601 . . . . 0.0 114.658 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -130.6 -57.39 1.06 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 125.933 1.693 . . . . 0.0 113.12 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.08 -80.62 0.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -149.12 12.93 0.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 120.966 3.691 . . . . 0.0 120.966 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -85.68 39.09 0.78 Allowed 'General case' 0 N--CA 1.516 2.83 0 CA-C-N 122.543 2.429 . . . . 0.0 108.671 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p 152.43 -28.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.091 0 C-N-CA 130.63 3.572 . . . . 0.0 109.021 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.16 55.43 3.1 Favored Glycine 0 N--CA 1.491 2.365 0 CA-C-N 122.685 2.493 . . . . 0.0 109.596 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m 63.6 95.38 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.155 1.382 . . . . 0.0 112.648 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 149.52 47.77 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.139 0 C-N-CA 127.4 2.28 . . . . 0.0 111.239 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 63.4 3.22 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 117.206 -3.434 . . . . 0.0 103.737 175.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.58 4.103 0 N-CA-C 105.524 -3.03 . . . . 0.0 105.524 -169.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 tptt . . . . . 0 CA--C 1.574 1.899 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 pp -142.9 1.69 1.3 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 119.201 3.038 . . . . 0.0 119.201 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 12' ' ' ALA . 45.1 t -57.58 99.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.249 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -91.58 -0.17 57.56 Favored 'General case' 0 CA--C 1.58 2.123 0 C-N-CA 128.979 2.912 . . . . 0.0 115.123 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -122.7 -36.01 2.97 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -110.66 -99.93 0.4 Allowed 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 119.997 3.332 . . . . 0.0 119.997 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.49 14.42 4.51 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -82.81 20.28 1.19 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 122.288 2.313 . . . . 0.0 112.421 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 p 169.13 -24.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.035 0 C-N-CA 130.314 3.446 . . . . 0.0 109.581 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.92 69.55 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-N 123.012 2.642 . . . . 0.0 109.339 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 m 50.51 46.24 25.66 Favored 'General case' 0 CA--C 1.595 2.677 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -174.11 72.42 0.03 OUTLIER 'General case' 0 CA--C 1.581 2.162 0 O-C-N 118.797 -2.44 . . . . 0.0 111.01 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -88.52 65.08 7.73 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 119.509 -1.995 . . . . 0.0 108.581 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.686 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -172.114 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 123.318 1.533 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tp -159.32 -56.55 0.06 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.822 -1.174 . . . . 0.0 111.368 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 12' ' ' ALA . 42.5 t -51.13 103.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 126.864 3.221 . . . . 0.0 117.405 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -88.56 -9.5 52.06 Favored 'General case' 0 CA--C 1.577 2.007 0 CA-C-N 108.546 -3.934 . . . . 0.0 114.811 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -115.46 -14.89 11.54 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 127.191 2.196 . . . . 0.0 116.227 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.517 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -147.64 -70.5 0.23 Allowed 'General case' 0 CA--C 1.562 1.44 1 N-CA-C 124.291 4.923 . . . . 0.0 124.291 -174.458 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -129.52 -17.56 3.68 Favored 'General case' 0 N--CA 1.504 2.241 1 N-CA-C 126.967 5.914 . . . . 0.0 126.967 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.2 27.7 0.67 Allowed 'General case' 0 N--CA 1.52 3.055 0 CA-C-N 123.806 3.003 . . . . 0.0 111.549 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p 176.45 -32.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 C-N-CA 128.902 2.881 . . . . 0.0 110.66 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.92 65.18 0.79 Allowed Glycine 0 N--CA 1.489 2.17 0 CA-C-N 121.766 2.076 . . . . 0.0 110.558 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m 50.91 45.9 26.94 Favored 'General case' 0 CA--C 1.586 2.354 0 N-CA-C 117.884 2.55 . . . . 0.0 117.884 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -173.17 74.14 0.04 OUTLIER 'General case' 0 CA--C 1.576 1.949 0 O-C-N 119.669 -1.894 . . . . 0.0 111.094 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.71 62.78 3.29 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 119.942 -1.724 . . . . 0.0 107.454 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.477 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 -171.745 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.85 -52.64 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.069 0.948 . . . . 0.0 112.38 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 12' ' ' ALA . 9.6 t -53.44 148.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 CA-C-O 124.674 2.178 . . . . 0.0 115.682 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 -51.15 2.21 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 111.215 -2.721 . . . . 0.0 109.725 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -91.72 10.41 28.46 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.693 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -138.32 -109.52 0.17 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 123.696 2.953 . . . . 0.0 116.688 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -125.88 17.53 7.96 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.89 1.66 55.33 Favored 'General case' 0 CA--C 1.599 2.843 0 O-C-N 119.82 -1.8 . . . . 0.0 110.351 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 m -151.48 -40.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.904 0 C-N-CA 129.301 3.04 . . . . 0.0 110.085 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.85 62.31 0.56 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.93 1.241 . . . . 0.0 114.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.5 t 35.54 45.84 0.26 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 119.612 3.19 . . . . 0.0 119.612 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -101.65 -1.58 32.36 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.3 pttt 67.44 -49.99 0.5 Allowed 'General case' 0 N--CA 1.515 2.81 0 C-N-CA 128.059 2.544 . . . . 0.0 112.032 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 2.883 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.6 175.851 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptt . . . . . 0 N--CA 1.507 2.396 0 CA-C-O 122.168 0.985 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -164.13 -52.92 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 124.394 1.078 . . . . 0.0 112.639 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.37 152.4 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.092 0 CA-C-O 126.293 2.949 . . . . 0.0 116.452 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 -66.43 1.0 Allowed 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 109.845 -3.343 . . . . 0.0 108.138 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.64 7.98 2.66 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.12 -94.14 0.05 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.715 2.857 . . . . 0.0 118.715 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -98.87 7.26 46.23 Favored 'General case' 0 N--CA 1.496 1.835 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -171.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.74 30.25 4.09 Favored 'General case' 0 N--CA 1.517 2.898 0 CA-C-N 121.355 1.889 . . . . 0.0 109.451 172.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 p 176.54 -39.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 126.986 2.114 . . . . 0.0 112.11 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 63.63 0.57 Allowed Glycine 0 CA--C 1.55 2.231 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t 50.49 56.67 7.59 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 119.398 3.111 . . . . 0.0 119.398 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.91 -54.24 4.34 Favored 'General case' 0 CA--C 1.579 2.086 0 CA-C-N 121.629 2.013 . . . . 0.0 112.431 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 117.89 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 129.872 3.269 . . . . 0.0 107.852 -175.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.699 0 CA-C-O 117.971 -1.461 . . . . 0.0 113.766 174.949 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -176.61 -8.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 12' ' ' ALA . 2.2 t -75.06 138.74 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 CA-C-O 126.081 2.848 . . . . 0.0 116.824 -171.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.17 -35.01 5.76 Favored 'General case' 0 CA--C 1.579 2.073 0 CA-C-N 109.157 -3.656 . . . . 0.0 110.369 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -98.44 20.86 11.98 Favored 'General case' 0 CA--C 1.589 2.462 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.786 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -146.75 -104.91 0.09 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 121.928 2.149 . . . . 0.0 115.287 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -128.07 6.65 5.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -83.73 17.22 2.37 Favored 'General case' 0 CA--C 1.606 3.125 0 O-C-N 120.191 -1.568 . . . . 0.0 111.64 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.54 -42.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 C-N-CA 129.697 3.199 . . . . 0.0 108.698 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.82 50.23 0.36 Allowed Glycine 0 N--CA 1.486 1.997 0 CA-C-N 119.34 0.973 . . . . 0.0 114.712 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t 49.27 36.33 9.2 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 120.651 3.575 . . . . 0.0 120.651 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -86.9 -4.64 59.2 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 123.475 2.852 . . . . 0.0 114.088 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.81 10.29 0.36 Allowed 'General case' 0 N--CA 1.525 3.294 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.564 0 C-N-CA 127.628 2.537 . . . . 0.0 109.548 178.593 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.81 -11.53 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 12' ' ' ALA . 46.1 t -77.33 131.18 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.057 0 CA-C-O 125.918 2.771 . . . . 0.0 116.063 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.43 -57.81 1.99 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 109.762 -3.381 . . . . 0.0 109.875 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.97 -8.12 55.58 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.459 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -140.45 -99.38 0.15 Allowed 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 121.655 3.946 . . . . 0.0 121.655 -175.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -106.28 5.47 29.77 Favored 'General case' 0 N--CA 1.5 2.064 1 N-CA-C 123.525 4.639 . . . . 0.0 123.525 -170.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.5 7.81 18.62 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 122.086 2.221 . . . . 0.0 112.489 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -171.55 -23.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.04 0 C-N-CA 127.983 2.513 . . . . 0.0 111.743 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.9 66.51 0.83 Allowed Glycine 0 N--CA 1.494 2.516 0 CA-C-N 122.85 2.568 . . . . 0.0 109.644 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 m 47.97 32.31 2.79 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -100.15 93.29 5.64 Favored 'General case' 0 CA--C 1.563 1.453 0 O-C-N 119.825 -1.797 . . . . 0.0 107.15 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 67.44 0.22 Allowed 'General case' 0 CA--C 1.573 1.85 0 CA-C-O 124.641 2.162 . . . . 0.0 114.649 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.563 0 CA-C-N 113.288 -1.778 . . . . 0.0 116.177 -179.223 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.59 -8.49 0.14 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 14' ' ' ASP . 50.1 t -69.17 130.55 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.322 0 CA-C-O 126.281 2.944 . . . . 0.0 115.782 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -111.91 -54.68 2.59 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 109.923 -3.308 . . . . 0.0 109.024 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -74.16 -7.74 53.69 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.22 -104.22 0.18 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -107.57 4.81 26.38 Favored 'General case' 0 N--CA 1.501 2.102 1 N-CA-C 122.089 4.107 . . . . 0.0 122.089 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.416 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 99.6 m-20 -89.5 11.41 19.51 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 121.448 1.931 . . . . 0.0 111.382 172.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -164.67 -36.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 127.38 2.272 . . . . 0.0 111.34 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.73 63.88 0.6 Allowed Glycine 0 N--CA 1.495 2.574 0 CA-C-N 121.006 1.73 . . . . 0.0 111.952 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 m 39.74 49.25 2.08 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 121.137 3.754 . . . . 0.0 121.137 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.13 -22.79 33.24 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 119.725 -1.86 . . . . 0.0 112.85 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt 54.59 35.22 23.06 Favored 'General case' 0 N--CA 1.52 3.039 0 CA-C-O 124.239 1.971 . . . . 0.0 113.473 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.794 0 C-N-CA 128.18 2.8 . . . . 0.0 110.353 -178.658 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.9 tptm . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.02 -10.12 12.9 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 12' ' ' ALA . 15.1 t -69.44 134.72 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.039 0 CA-C-N 124.508 3.322 . . . . 0.0 115.679 -172.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.6 -50.83 2.19 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 127.202 2.201 . . . . 0.0 109.901 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -80.55 -0.31 37.09 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -137.64 -109.11 0.18 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 118.034 2.605 . . . . 0.0 118.034 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.07 15.46 26.38 Favored 'General case' 0 N--CA 1.497 1.915 1 N-CA-C 121.839 4.014 . . . . 0.0 121.839 -172.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.21 11.08 26.86 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 121.686 2.039 . . . . 0.0 110.889 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -171.51 -29.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 C-N-CA 128.436 2.694 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.87 63.26 0.75 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 121.807 2.094 . . . . 0.0 110.42 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m 42.77 46.68 4.54 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -82.19 -23.97 35.21 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 119.228 -2.17 . . . . 0.0 114.135 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.61 33.89 17.45 Favored 'General case' 0 N--CA 1.523 3.216 0 CA-C-N 121.966 2.166 . . . . 0.0 114.566 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.732 0 C-N-CA 128.143 2.782 . . . . 0.0 108.605 -178.839 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt . . . . . 0 CA--C 1.567 1.614 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -169.1 -10.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 12' ' ' ALA . 2.3 t -78.24 126.94 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 125.913 2.768 . . . . 0.0 117.991 -171.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.62 -5.26 32.16 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-N 109.826 -3.352 . . . . 0.0 113.586 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.583 ' H ' HG12 ' A' ' 9' ' ' VAL . 30.4 p90 -130.79 18.1 5.16 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.003 2.121 . . . . 0.0 113.647 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.658 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -143.49 -105.54 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 121.254 1.843 . . . . 0.0 115.676 -175.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.99 12.56 4.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -83.63 20.58 1.38 Allowed 'General case' 0 N--CA 1.517 2.881 0 O-C-N 119.424 -2.048 . . . . 0.0 113.611 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p 168.47 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 C-N-CA 131.641 3.976 . . . . 0.0 107.624 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.59 61.79 0.54 Allowed Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.678 1.581 . . . . 0.0 111.209 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t 51.18 25.56 2.48 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -106.12 107.04 17.84 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-N 123.027 2.649 . . . . 0.0 107.272 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -57.35 -32.81 67.11 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 3.086 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 173.559 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 64.9 t80 . . . . . 0 CA--C 1.566 1.593 0 CA-C-O 121.628 0.727 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -84.3 -14.8 48.75 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t 69.42 -51.99 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 C-N-CA 126.678 1.991 . . . . 0.0 112.911 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.1 m170 71.53 -34.19 0.29 Allowed 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.258 1.823 . . . . 0.0 112.894 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 m80 64.43 162.46 0.12 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.592 1.957 . . . . 0.0 116.136 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 44.03 42.24 4.64 Favored 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 129.317 3.047 . . . . 0.0 117.693 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -138.08 -64.68 0.53 Allowed 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.57 0.91 0.3 Allowed 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 12' ' ' ALA . 12.3 t -68.27 99.06 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 CA-C-N 123.569 2.895 . . . . 0.0 118.293 -171.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -89.96 -14.15 34.69 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 129.068 2.947 . . . . 0.0 115.057 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -112.26 -1.67 15.09 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -149.27 -90.3 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -130.07 9.81 5.33 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 121.042 3.719 . . . . 0.0 121.042 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.51 31.93 0.66 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.253 2.297 . . . . 0.0 110.217 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p 158.16 -27.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 C-N-CA 129.599 3.159 . . . . 0.0 109.855 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.23 66.35 0.79 Allowed Glycine 0 N--CA 1.49 2.247 0 CA-C-N 122.68 2.491 . . . . 0.0 109.159 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.9 m 49.12 49.0 20.27 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 118.097 2.628 . . . . 0.0 118.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -174.44 70.77 0.03 OUTLIER 'General case' 0 CA--C 1.577 2.005 0 O-C-N 119.396 -2.065 . . . . 0.0 110.372 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 57.72 4.51 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.721 -1.862 . . . . 0.0 108.665 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.59 51.32 59.41 Favored Glycine 0 CA--C 1.569 3.454 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -171.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.257 . . -147.49 -37.28 0.21 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 121.233 3.79 . . . . 0.0 121.233 -170.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 mp 58.03 36.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.618 3.579 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mt 68.63 90.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 1.992 0 C-N-CA 127.997 2.519 . . . . 0.0 108.531 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 174.69 -91.3 0.08 OUTLIER Glycine 0 N--CA 1.484 1.869 0 O-C-N 121.585 -0.697 . . . . 0.0 112.779 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -143.7 162.58 35.6 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.727 0.775 . . . . 0.0 111.499 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 123.746 1.736 . . . . 0.0 110.9 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.1 t80 . . . . . 0 CA--C 1.564 1.496 0 CA-C-O 121.336 0.589 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -79.38 0.4 Allowed 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 p -149.91 89.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -87.27 66.89 9.4 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 103.198 -2.89 . . . . 0.0 103.198 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -5.21 115.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 119.742 3.238 . . . . 0.0 119.742 -172.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.64 -92.94 0.14 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 115.44 -2.219 . . . . 0.0 109.201 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -165.74 -39.62 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 CA-C-N 123.67 2.941 . . . . 0.0 118.068 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -69.85 -9.27 54.16 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 12' ' ' ALA . 41.7 t -56.45 123.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-O 124.013 1.863 . . . . 0.0 115.983 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -115.86 -3.18 12.21 Favored 'General case' 0 CA--C 1.585 2.298 0 C-N-CA 130.748 3.619 . . . . 0.0 113.756 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.78 -3.47 6.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -176.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -141.95 -102.27 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.91 10.19 5.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.41 44.86 1.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 122.503 2.411 . . . . 0.0 108.132 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p 150.68 -33.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 C-N-CA 130.39 3.476 . . . . 0.0 109.311 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 58.81 0.84 Allowed Glycine 0 N--CA 1.49 2.29 0 CA-C-N 121.819 2.1 . . . . 0.0 111.992 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m 54.01 44.42 29.35 Favored 'General case' 0 CA--C 1.59 2.497 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.59 63.27 0.05 Allowed 'General case' 0 CA--C 1.583 2.241 0 O-C-N 119.081 -2.262 . . . . 0.0 113.284 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -83.73 66.28 8.96 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 118.502 -2.624 . . . . 0.0 109.002 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.26 46.51 79.1 Favored Glycine 0 N--CA 1.51 3.633 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -171.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.267 . . -142.51 -52.53 0.4 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 121.33 3.826 . . . . 0.0 121.33 -169.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 mm 61.89 32.92 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.608 3.202 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mt 64.9 81.58 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.075 0 C-N-CA 126.758 2.023 . . . . 0.0 108.498 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.53 -50.72 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 119.072 2.389 . . . . 0.0 119.072 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.2 tp -138.93 120.42 15.01 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 119.239 1.519 . . . . 0.0 110.469 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 124.364 2.031 . . . . 0.0 111.813 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 17.1 t80 . . . . . 0 CA--C 1.566 1.573 0 CA-C-O 121.851 0.834 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -102.58 81.24 2.01 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-O 122.919 1.342 . . . . 0.0 108.38 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 t -58.05 106.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.535 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -86.56 78.77 9.12 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -29.53 133.17 0.05 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 120.892 3.664 . . . . 0.0 120.892 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.43 -85.31 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 117.538 -1.22 . . . . 0.0 111.077 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.45 -20.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 tp -65.91 -53.89 33.5 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.984 2.629 . . . . 0.0 117.425 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 12' ' ' ALA . 39.3 t -40.28 130.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 126.386 2.993 . . . . 0.0 116.572 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.04 7.59 7.29 Favored 'General case' 0 CA--C 1.584 2.252 1 CA-C-N 107.775 -4.284 . . . . 0.0 114.563 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -128.74 -43.61 1.37 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.81 2.044 . . . . 0.0 113.389 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -98.54 -95.32 0.23 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -136.72 14.61 3.14 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 120.329 3.455 . . . . 0.0 120.329 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 1.8 m-20 -85.23 23.81 1.22 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 122.5 2.409 . . . . 0.0 110.672 173.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 p 168.05 -27.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 C-N-CA 131.185 3.794 . . . . 0.0 109.445 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.49 70.74 1.14 Allowed Glycine 0 N--CA 1.49 2.295 0 CA-C-N 122.944 2.611 . . . . 0.0 111.11 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m 51.54 39.41 24.7 Favored 'General case' 0 CA--C 1.592 2.592 0 N-CA-C 119.936 3.31 . . . . 0.0 119.936 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -173.78 78.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 118.693 -2.504 . . . . 0.0 111.643 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -104.65 70.43 0.94 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 57.25 52.45 51.45 Favored Glycine 0 N--CA 1.51 3.595 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.253 . . -152.8 -50.96 0.1 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 120.974 3.694 . . . . 0.0 120.974 -170.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mp 58.94 31.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.613 3.378 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.8 mt 62.84 71.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 119.226 -2.171 . . . . 0.0 107.11 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.05 -24.84 0.12 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 121.4 3.32 . . . . 0.0 121.4 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.3 -87.3 0.47 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 121.802 2.801 . . . . 0.0 105.801 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 123.682 1.706 . . . . 0.0 108.295 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 CA--C 1.57 1.718 0 CA-C-O 117.722 -1.132 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -150.5 -56.83 0.17 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 121.3 1.864 . . . . 0.0 112.839 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 9' ' ' VAL . 7.7 m -41.75 121.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 123.661 1.696 . . . . 0.0 114.667 -176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -121.25 90.85 3.4 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.457 ' H ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 91.46 170.22 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 129.75 3.22 . . . . 0.0 109.655 -178.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 122.52 -73.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 128.953 2.901 . . . . 0.0 106.424 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -153.99 -46.68 0.09 Allowed 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -97.96 3.07 49.61 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 119.037 2.977 . . . . 0.0 119.037 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.462 HG22 HG23 ' A' ' 3' ' ' VAL . 3.7 t -72.72 94.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 N-CA-C 120.081 3.363 . . . . 0.0 120.081 -169.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -81.32 -23.08 38.05 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 128.648 2.779 . . . . 0.0 114.666 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -100.65 -16.91 17.26 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -139.72 -82.91 0.26 Allowed 'General case' 0 CA--C 1.555 1.158 1 N-CA-C 123.12 4.489 . . . . 0.0 123.12 -172.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -127.23 -1.12 6.39 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.481 3.882 . . . . 0.0 121.481 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.21 25.98 0.22 Allowed 'General case' 0 N--CA 1.521 3.109 0 CA-C-N 123.086 2.676 . . . . 0.0 111.898 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 p 164.91 -27.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.033 0 C-N-CA 129.642 3.177 . . . . 0.0 110.643 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.93 68.66 0.77 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 122.459 2.39 . . . . 0.0 108.074 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.1 m 46.03 45.78 12.39 Favored 'General case' 0 CA--C 1.593 2.612 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -171.39 72.34 0.05 OUTLIER 'General case' 0 CA--C 1.577 2.018 0 O-C-N 119.39 -2.069 . . . . 0.0 110.36 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.9 58.02 4.83 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 119.953 -1.717 . . . . 0.0 109.068 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.25 54.64 36.25 Favored Glycine 0 N--CA 1.51 3.608 0 N-CA-C 105.968 -2.853 . . . . 0.0 105.968 -170.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.266 . . -147.51 -39.54 0.19 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 121.762 3.986 . . . . 0.0 121.762 -169.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mm 61.79 26.16 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.614 3.425 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -172.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mt 69.72 81.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 C-N-CA 127.449 2.3 . . . . 0.0 107.723 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.08 -56.68 0.44 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 115.713 1.045 . . . . 0.0 115.713 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.8 mt -87.92 179.47 6.44 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 117.833 0.816 . . . . 0.0 111.986 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 123.996 1.855 . . . . 0.0 108.808 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 21.5 t80 . . . . . 0 CA--C 1.563 1.456 0 CA-C-O 121.309 0.576 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.38 -41.82 6.88 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.5 m -77.79 87.43 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 123.031 1.396 . . . . 0.0 110.966 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -84.63 74.99 10.34 Favored 'General case' 0 CA--C 1.581 2.147 0 O-C-N 120.008 -1.683 . . . . 0.0 109.936 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.8 m80 1.07 132.64 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.118 1 N-CA-C 123.752 4.723 . . . . 0.0 123.752 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 67.82 68.41 0.35 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 129.167 2.987 . . . . 0.0 111.477 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.01 -53.43 1.74 Allowed 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 113.291 -1.777 . . . . 0.0 112.411 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -173.36 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 125.302 1.441 . . . . 0.0 111.817 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -16.25 101.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.589 2.453 0 C-N-CA 130.685 3.594 . . . . 0.0 118.067 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -100.45 -4.01 29.75 Favored 'General case' 0 CA--C 1.585 2.292 1 CA-C-N 107.562 -4.381 . . . . 0.0 114.01 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -119.8 -8.8 9.82 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 127.559 2.344 . . . . 0.0 116.133 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.94 -86.36 0.11 Allowed 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 119.412 3.115 . . . . 0.0 119.412 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -125.49 4.32 7.63 Favored 'General case' 0 N--CA 1.498 1.937 1 N-CA-C 122.591 4.293 . . . . 0.0 122.591 -172.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.81 9.11 4.48 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 121.77 2.077 . . . . 0.0 112.737 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p 176.51 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 C-N-CA 129.737 3.215 . . . . 0.0 111.335 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.68 58.73 0.89 Allowed Glycine 0 N--CA 1.494 2.529 0 CA-C-N 122.869 2.577 . . . . 0.0 109.789 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p 52.63 50.6 17.81 Favored 'General case' 0 CA--C 1.589 2.468 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -173.7 68.82 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.902 0 O-C-N 119.566 -1.959 . . . . 0.0 110.384 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.76 59.99 3.34 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.802 -1.811 . . . . 0.0 108.463 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.2 57.41 15.54 Favored Glycine 0 N--CA 1.503 3.151 0 N-CA-C 106.368 -2.693 . . . . 0.0 106.368 -172.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.22 -41.17 0.09 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 120.586 3.55 . . . . 0.0 120.586 -171.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.8 mm 60.03 29.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.613 3.378 0 CA-C-N 119.622 1.101 . . . . 0.0 108.263 -172.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 mt 70.0 86.24 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 C-N-CA 127.389 2.275 . . . . 0.0 107.861 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.51 -81.29 0.07 OUTLIER Glycine 0 N--CA 1.485 1.933 0 O-C-N 121.262 -0.899 . . . . 0.0 114.68 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 pp -136.92 164.05 29.23 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.169 0.985 . . . . 0.0 112.271 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 35.2 mmt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 123.505 1.621 . . . . 0.0 110.154 179.445 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 CA--C 1.562 1.433 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.82 78.02 1.77 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.306 1.051 . . . . 0.0 108.519 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -86.05 114.2 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.87 -1.144 . . . . 0.0 108.288 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -66.12 -20.34 66.12 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.4 m80 61.13 165.62 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.453 2.019 . . . . 0.0 116.453 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 42.47 42.28 2.64 Favored 'General case' 0 CA--C 1.577 2.014 0 C-N-CA 129.283 3.033 . . . . 0.0 118.268 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -138.05 -61.94 0.6 Allowed 'General case' 0 CA--C 1.567 1.61 0 O-C-N 121.078 -1.014 . . . . 0.0 113.223 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.54 -43.47 0.19 Allowed 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 t -25.48 105.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.591 2.537 0 CA-C-O 127.292 3.425 . . . . 0.0 116.77 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -106.41 7.06 30.91 Favored 'General case' 0 CA--C 1.577 2.001 2 CA-C-N 107.077 -4.601 . . . . 0.0 114.658 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -130.6 -57.39 1.06 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 125.933 1.693 . . . . 0.0 113.12 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.08 -80.62 0.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -149.12 12.93 0.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 120.966 3.691 . . . . 0.0 120.966 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -85.68 39.09 0.78 Allowed 'General case' 0 N--CA 1.516 2.83 0 CA-C-N 122.543 2.429 . . . . 0.0 108.671 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p 152.43 -28.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.091 0 C-N-CA 130.63 3.572 . . . . 0.0 109.021 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.16 55.43 3.1 Favored Glycine 0 N--CA 1.491 2.365 0 CA-C-N 122.685 2.493 . . . . 0.0 109.596 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m 63.6 95.38 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.155 1.382 . . . . 0.0 112.648 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 149.52 47.77 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.139 0 C-N-CA 127.4 2.28 . . . . 0.0 111.239 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 63.4 3.22 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 117.206 -3.434 . . . . 0.0 103.737 175.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.15 -57.22 4.79 Favored Glycine 1 CA--C 1.58 4.103 0 N-CA-C 105.524 -3.03 . . . . 0.0 105.524 -169.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.31 117.31 25.03 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.84 2.856 . . . . 0.0 115.234 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.52 65.61 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.225 0 N-CA-C 102.764 -3.05 . . . . 0.0 102.764 172.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.2 mt 71.25 86.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.581 2.136 0 C-N-CA 126.526 1.931 . . . . 0.0 106.825 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -177.51 -103.33 0.17 Allowed Glycine 0 N--CA 1.487 2.05 0 O-C-N 121.098 -1.001 . . . . 0.0 115.44 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -141.17 149.84 41.98 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.652 1.215 . . . . 0.0 112.281 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 124.869 2.271 . . . . 0.0 112.65 -179.46 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 38.8 t80 . . . . . 0 CA--C 1.567 1.632 0 CA-C-O 121.812 0.815 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.88 -32.55 72.28 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t 70.54 -50.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 C-N-CA 126.09 1.756 . . . . 0.0 111.717 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 70.36 -34.61 0.3 Allowed 'General case' 0 N--CA 1.515 2.799 0 CA-C-N 121.42 1.918 . . . . 0.0 113.318 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.3 m80 70.3 148.19 0.07 Allowed 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 127.795 2.438 . . . . 0.0 116.472 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 64.81 72.79 0.43 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 129.626 3.17 . . . . 0.0 113.322 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -157.78 -88.19 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.899 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.708 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 pp -142.9 1.69 1.3 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 119.201 3.038 . . . . 0.0 119.201 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 12' ' ' ALA . 45.1 t -57.58 99.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.249 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -91.58 -0.17 57.56 Favored 'General case' 0 CA--C 1.58 2.123 0 C-N-CA 128.979 2.912 . . . . 0.0 115.123 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -122.7 -36.01 2.97 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -110.66 -99.93 0.4 Allowed 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 119.997 3.332 . . . . 0.0 119.997 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.49 14.42 4.51 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -82.81 20.28 1.19 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 122.288 2.313 . . . . 0.0 112.421 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 p 169.13 -24.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.035 0 C-N-CA 130.314 3.446 . . . . 0.0 109.581 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.92 69.55 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-N 123.012 2.642 . . . . 0.0 109.339 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 m 50.51 46.24 25.66 Favored 'General case' 0 CA--C 1.595 2.677 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -174.11 72.42 0.03 OUTLIER 'General case' 0 CA--C 1.581 2.162 0 O-C-N 118.797 -2.44 . . . . 0.0 111.01 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -88.52 65.08 7.73 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 119.509 -1.995 . . . . 0.0 108.581 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 57.7 45.12 93.72 Favored Glycine 0 N--CA 1.511 3.686 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.61 -39.99 0.71 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 120.659 3.578 . . . . 0.0 120.659 -171.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 mp 75.0 -48.64 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.599 2.85 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 -173.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.0 tp 176.07 97.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.29 -42.44 1.42 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 121.368 3.307 . . . . 0.0 121.368 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.05 90.07 2.47 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 118.957 1.379 . . . . 0.0 113.511 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.1 mmt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 124.79 2.233 . . . . 0.0 112.582 -179.419 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 85.9 t80 . . . . . 0 CA--C 1.565 1.55 0 CA-C-O 121.025 0.44 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -151.91 90.33 1.53 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.59 119.22 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 119.932 -1.73 . . . . 0.0 107.218 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -83.92 72.07 10.45 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -98.01 149.11 22.8 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 125.544 1.538 . . . . 0.0 113.861 -175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.18 -54.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.417 1.087 . . . . 0.0 108.571 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.54 72.59 0.09 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 123.318 1.533 . . . . 0.0 108.622 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tp -159.32 -56.55 0.06 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.822 -1.174 . . . . 0.0 111.368 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 12' ' ' ALA . 42.5 t -51.13 103.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 126.864 3.221 . . . . 0.0 117.405 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -88.56 -9.5 52.06 Favored 'General case' 0 CA--C 1.577 2.007 0 CA-C-N 108.546 -3.934 . . . . 0.0 114.811 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -115.46 -14.89 11.54 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 127.191 2.196 . . . . 0.0 116.227 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.517 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -147.64 -70.5 0.23 Allowed 'General case' 0 CA--C 1.562 1.44 1 N-CA-C 124.291 4.923 . . . . 0.0 124.291 -174.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -129.52 -17.56 3.68 Favored 'General case' 0 N--CA 1.504 2.241 1 N-CA-C 126.967 5.914 . . . . 0.0 126.967 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.2 27.7 0.67 Allowed 'General case' 0 N--CA 1.52 3.055 0 CA-C-N 123.806 3.003 . . . . 0.0 111.549 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p 176.45 -32.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 C-N-CA 128.902 2.881 . . . . 0.0 110.66 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.92 65.18 0.79 Allowed Glycine 0 N--CA 1.489 2.17 0 CA-C-N 121.766 2.076 . . . . 0.0 110.558 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m 50.91 45.9 26.94 Favored 'General case' 0 CA--C 1.586 2.354 0 N-CA-C 117.884 2.55 . . . . 0.0 117.884 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -173.17 74.14 0.04 OUTLIER 'General case' 0 CA--C 1.576 1.949 0 O-C-N 119.669 -1.894 . . . . 0.0 111.094 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.71 62.78 3.29 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 119.942 -1.724 . . . . 0.0 107.454 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.85 51.89 56.44 Favored Glycine 0 N--CA 1.508 3.477 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.253 . . -147.7 -42.74 0.17 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 120.614 3.561 . . . . 0.0 120.614 -170.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.1 mp 57.86 35.99 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.614 3.42 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt 66.93 83.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 C-N-CA 127.337 2.255 . . . . 0.0 109.223 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.01 -65.57 0.3 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 118.163 2.025 . . . . 0.0 118.163 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 pp -102.62 -177.36 3.36 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 9.7 mmt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 123.865 1.793 . . . . 0.0 108.015 179.725 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 37.1 t80 . . . . . 0 CA--C 1.565 1.542 0 CA-C-O 121.603 0.716 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -65.93 -31.15 71.91 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 t 71.86 89.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 126.363 1.865 . . . . 0.0 107.401 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -84.53 74.15 10.44 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -34.21 117.28 0.33 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 119.994 3.331 . . . . 0.0 119.994 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.5 1.8 0.03 OUTLIER 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 117.997 2.592 . . . . 0.0 117.997 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt 84.92 87.05 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 127.286 2.234 . . . . 0.0 107.947 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.85 -52.64 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.069 0.948 . . . . 0.0 112.38 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 12' ' ' ALA . 9.6 t -53.44 148.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 CA-C-O 124.674 2.178 . . . . 0.0 115.682 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 -51.15 2.21 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 111.215 -2.721 . . . . 0.0 109.725 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -91.72 10.41 28.46 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.693 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -138.32 -109.52 0.17 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 123.696 2.953 . . . . 0.0 116.688 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -125.88 17.53 7.96 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.89 1.66 55.33 Favored 'General case' 0 CA--C 1.599 2.843 0 O-C-N 119.82 -1.8 . . . . 0.0 110.351 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 m -151.48 -40.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.904 0 C-N-CA 129.301 3.04 . . . . 0.0 110.085 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.85 62.31 0.56 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.93 1.241 . . . . 0.0 114.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.5 t 35.54 45.84 0.26 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 119.612 3.19 . . . . 0.0 119.612 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -101.65 -1.58 32.36 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.3 pttt 67.44 -49.99 0.5 Allowed 'General case' 0 N--CA 1.515 2.81 0 C-N-CA 128.059 2.544 . . . . 0.0 112.032 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.48 -10.93 39.98 Favored Glycine 0 CA--C 1.56 2.883 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.6 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.41 77.48 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.155 1.782 . . . . 0.0 114.385 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.8 mt -82.65 50.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.595 2.708 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.35 -61.65 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 O-C-N 120.554 -1.341 . . . . 0.0 108.097 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.03 67.06 0.05 OUTLIER Glycine 0 N--CA 1.485 1.936 0 CA-C-N 119.502 1.046 . . . . 0.0 112.984 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -153.07 -80.6 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.076 0.938 . . . . 0.0 110.037 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-N 119.897 1.226 . . . . 0.0 113.601 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 39.3 t80 . . . . . 0 CA--C 1.567 1.614 0 CA-C-O 122.37 1.081 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.91 92.4 2.6 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.81 120.88 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 O-C-N 120.939 -1.101 . . . . 0.0 110.387 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.8 103.95 15.91 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -131.08 -67.81 0.69 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.033 0.933 . . . . 0.0 109.718 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 54.78 62.14 2.66 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 127.716 2.406 . . . . 0.0 113.281 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 93.03 81.75 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 126.915 2.086 . . . . 0.0 111.274 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -164.13 -52.92 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 124.394 1.078 . . . . 0.0 112.639 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.37 152.4 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.092 0 CA-C-O 126.293 2.949 . . . . 0.0 116.452 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 -66.43 1.0 Allowed 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 109.845 -3.343 . . . . 0.0 108.138 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.64 7.98 2.66 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.12 -94.14 0.05 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.715 2.857 . . . . 0.0 118.715 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -98.87 7.26 46.23 Favored 'General case' 0 N--CA 1.496 1.835 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -171.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.74 30.25 4.09 Favored 'General case' 0 N--CA 1.517 2.898 0 CA-C-N 121.355 1.889 . . . . 0.0 109.451 172.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 p 176.54 -39.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 126.986 2.114 . . . . 0.0 112.11 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 63.63 0.57 Allowed Glycine 0 CA--C 1.55 2.231 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t 50.49 56.67 7.59 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 119.398 3.111 . . . . 0.0 119.398 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.91 -54.24 4.34 Favored 'General case' 0 CA--C 1.579 2.086 0 CA-C-N 121.629 2.013 . . . . 0.0 112.431 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 117.89 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 129.872 3.269 . . . . 0.0 107.852 -175.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.03 -17.74 7.67 Favored Glycine 0 CA--C 1.557 2.699 0 CA-C-O 117.971 -1.461 . . . . 0.0 113.766 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.44 78.05 0.23 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 120.57 2.185 . . . . 0.0 111.303 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -80.9 63.62 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.372 0 CA-C-O 124.222 1.963 . . . . 0.0 105.903 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.3 mm -127.6 -58.18 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 C-N-CA 126.936 2.094 . . . . 0.0 105.73 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 167.04 58.78 0.03 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.79 -140.65 0.05 OUTLIER 'General case' 0 CA--C 1.582 2.18 0 CA-C-N 118.028 0.914 . . . . 0.0 108.78 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.981 0 O-C-N 118.577 -2.577 . . . . 0.0 115.24 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 17.3 p90 . . . . . 0 CA--C 1.566 1.572 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -148.83 -109.45 0.07 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.9 t 62.45 -41.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 67.14 82.6 0.18 Allowed 'General case' 0 N--CA 1.512 2.652 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -55.4 149.09 13.81 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 121.198 3.777 . . . . 0.0 121.198 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 65.38 75.27 0.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 110.385 -3.098 . . . . 0.0 113.025 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.65 -50.32 0.98 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.155 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -176.61 -8.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 12' ' ' ALA . 2.2 t -75.06 138.74 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 CA-C-O 126.081 2.848 . . . . 0.0 116.824 -171.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.17 -35.01 5.76 Favored 'General case' 0 CA--C 1.579 2.073 0 CA-C-N 109.157 -3.656 . . . . 0.0 110.369 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -98.44 20.86 11.98 Favored 'General case' 0 CA--C 1.589 2.462 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.786 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -146.75 -104.91 0.09 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 121.928 2.149 . . . . 0.0 115.287 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -128.07 6.65 5.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -83.73 17.22 2.37 Favored 'General case' 0 CA--C 1.606 3.125 0 O-C-N 120.191 -1.568 . . . . 0.0 111.64 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.54 -42.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 C-N-CA 129.697 3.199 . . . . 0.0 108.698 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.82 50.23 0.36 Allowed Glycine 0 N--CA 1.486 1.997 0 CA-C-N 119.34 0.973 . . . . 0.0 114.712 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t 49.27 36.33 9.2 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 120.651 3.575 . . . . 0.0 120.651 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -86.9 -4.64 59.2 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 123.475 2.852 . . . . 0.0 114.088 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.81 10.29 0.36 Allowed 'General case' 0 N--CA 1.525 3.294 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.95 -47.29 0.05 OUTLIER Glycine 0 CA--C 1.555 2.564 0 C-N-CA 127.628 2.537 . . . . 0.0 109.548 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 77.09 88.37 0.08 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.319 2.248 . . . . 0.0 113.907 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.8 mp -68.76 -34.23 63.62 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.537 0 CA-C-N 110.123 -3.217 . . . . 0.0 107.26 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.94 73.83 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.911 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.65 -50.0 0.25 Allowed Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.196 -0.94 . . . . 0.0 114.761 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 tm? 61.85 87.04 0.1 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 126.245 1.818 . . . . 0.0 112.99 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 122.865 1.317 . . . . 0.0 109.883 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 CA--C 1.578 2.051 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -87.85 -69.84 0.67 Allowed 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 119.91 1.232 . . . . 0.0 112.557 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.3 m -91.62 108.96 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 122.618 1.199 . . . . 0.0 110.755 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -92.79 53.34 2.01 Favored 'General case' 0 CA--C 1.579 2.079 0 O-C-N 120.823 -1.173 . . . . 0.0 110.011 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 18.13 94.88 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 119.84 3.274 . . . . 0.0 119.84 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.34 -75.08 0.6 Allowed 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.26 80.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.741 1.216 . . . . 0.0 107.768 177.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.81 -11.53 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 12' ' ' ALA . 46.1 t -77.33 131.18 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.057 0 CA-C-O 125.918 2.771 . . . . 0.0 116.063 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.43 -57.81 1.99 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 109.762 -3.381 . . . . 0.0 109.875 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.97 -8.12 55.58 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.459 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -140.45 -99.38 0.15 Allowed 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 121.655 3.946 . . . . 0.0 121.655 -175.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -106.28 5.47 29.77 Favored 'General case' 0 N--CA 1.5 2.064 1 N-CA-C 123.525 4.639 . . . . 0.0 123.525 -170.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.5 7.81 18.62 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 122.086 2.221 . . . . 0.0 112.489 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -171.55 -23.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.04 0 C-N-CA 127.983 2.513 . . . . 0.0 111.743 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.9 66.51 0.83 Allowed Glycine 0 N--CA 1.494 2.516 0 CA-C-N 122.85 2.568 . . . . 0.0 109.644 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 m 47.97 32.31 2.79 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -100.15 93.29 5.64 Favored 'General case' 0 CA--C 1.563 1.453 0 O-C-N 119.825 -1.797 . . . . 0.0 107.15 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 67.44 0.22 Allowed 'General case' 0 CA--C 1.573 1.85 0 CA-C-O 124.641 2.162 . . . . 0.0 114.649 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.51 10.33 0.08 OUTLIER Glycine 0 CA--C 1.555 2.563 0 CA-C-N 113.288 -1.778 . . . . 0.0 116.177 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.82 -101.51 0.42 Allowed 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.1 mt 70.84 -76.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 tp -133.72 -13.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.311 0 C-N-CA 125.054 1.341 . . . . 0.0 112.319 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.11 65.51 0.47 Allowed Glycine 0 N--CA 1.49 2.27 0 CA-C-N 121.48 1.946 . . . . 0.0 113.498 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -150.35 -58.08 0.18 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.616 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -179.024 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 55.8 t80 . . . . . 0 CA--C 1.563 1.457 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -113.15 43.69 1.67 Allowed 'General case' 0 CA--C 1.581 2.173 0 CA-C-O 121.268 0.556 . . . . 0.0 111.827 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.22 104.27 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 119.783 -1.823 . . . . 0.0 108.46 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -91.25 74.79 6.17 Favored 'General case' 0 CA--C 1.577 2.007 0 CA-C-O 122.469 1.128 . . . . 0.0 108.081 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -27.11 145.06 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 121.67 3.952 . . . . 0.0 121.67 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 64.11 72.09 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 127.721 2.408 . . . . 0.0 108.86 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.6 -62.17 0.66 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.988 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.59 -8.49 0.14 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 14' ' ' ASP . 50.1 t -69.17 130.55 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.322 0 CA-C-O 126.281 2.944 . . . . 0.0 115.782 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -111.91 -54.68 2.59 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 109.923 -3.308 . . . . 0.0 109.024 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -74.16 -7.74 53.69 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.22 -104.22 0.18 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -107.57 4.81 26.38 Favored 'General case' 0 N--CA 1.501 2.102 1 N-CA-C 122.089 4.107 . . . . 0.0 122.089 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.416 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 99.6 m-20 -89.5 11.41 19.51 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 121.448 1.931 . . . . 0.0 111.382 172.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -164.67 -36.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 127.38 2.272 . . . . 0.0 111.34 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.73 63.88 0.6 Allowed Glycine 0 N--CA 1.495 2.574 0 CA-C-N 121.006 1.73 . . . . 0.0 111.952 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 m 39.74 49.25 2.08 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 121.137 3.754 . . . . 0.0 121.137 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.13 -22.79 33.24 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 119.725 -1.86 . . . . 0.0 112.85 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt 54.59 35.22 23.06 Favored 'General case' 0 N--CA 1.52 3.039 0 CA-C-O 124.239 1.971 . . . . 0.0 113.473 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.45 -39.83 0.08 OUTLIER Glycine 0 CA--C 1.559 2.794 0 C-N-CA 128.18 2.8 . . . . 0.0 110.353 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 67.88 83.52 0.16 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 126.529 1.932 . . . . 0.0 111.504 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.52 53.09 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.592 2.596 0 CA-C-N 112.83 -1.986 . . . . 0.0 105.738 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tp -119.35 -51.6 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 C-N-CA 125.194 1.398 . . . . 0.0 109.045 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.53 57.86 0.02 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 115.453 0.941 . . . . 0.0 115.453 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.31 -67.54 0.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 118.749 1.275 . . . . 0.0 109.915 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.5 mpp? . . . . . 0 N--CA 1.494 1.757 0 CA-C-N 120.761 1.619 . . . . 0.0 111.244 -179.558 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 56.8 t80 . . . . . 0 CA--C 1.565 1.526 0 CA-C-O 121.199 0.523 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -142.87 90.44 2.21 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 123.281 1.515 . . . . 0.0 107.347 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -67.68 -36.29 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 m170 72.79 -50.14 0.7 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-N 121.898 2.136 . . . . 0.0 111.807 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 71.92 132.34 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.757 0 C-N-CA 127.296 2.239 . . . . 0.0 114.556 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 68.33 57.4 0.46 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 128.502 2.721 . . . . 0.0 113.568 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -179.56 -62.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 123.76 0.824 . . . . 0.0 112.284 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.02 -10.12 12.9 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 12' ' ' ALA . 15.1 t -69.44 134.72 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.039 0 CA-C-N 124.508 3.322 . . . . 0.0 115.679 -172.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.6 -50.83 2.19 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 127.202 2.201 . . . . 0.0 109.901 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -80.55 -0.31 37.09 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -137.64 -109.11 0.18 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 118.034 2.605 . . . . 0.0 118.034 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.07 15.46 26.38 Favored 'General case' 0 N--CA 1.497 1.915 1 N-CA-C 121.839 4.014 . . . . 0.0 121.839 -172.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.21 11.08 26.86 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 121.686 2.039 . . . . 0.0 110.889 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -171.51 -29.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 C-N-CA 128.436 2.694 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.87 63.26 0.75 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 121.807 2.094 . . . . 0.0 110.42 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m 42.77 46.68 4.54 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -82.19 -23.97 35.21 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 119.228 -2.17 . . . . 0.0 114.135 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.61 33.89 17.45 Favored 'General case' 0 N--CA 1.523 3.216 0 CA-C-N 121.966 2.166 . . . . 0.0 114.566 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.29 -47.7 0.05 OUTLIER Glycine 0 CA--C 1.558 2.732 0 C-N-CA 128.143 2.782 . . . . 0.0 108.605 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 74.59 87.13 0.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 127.496 2.318 . . . . 0.0 114.539 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.6 -43.97 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.427 0 CA-C-N 112.197 -2.274 . . . . 0.0 105.342 173.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.93 74.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.083 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 167.02 -137.43 4.63 Favored Glycine 0 CA--C 1.546 1.974 0 O-C-N 121.172 -0.955 . . . . 0.0 113.195 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -157.5 -37.87 0.07 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.569 1.682 0 CA-C-O 125.01 2.338 . . . . 0.0 114.596 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 40.5 t80 . . . . . 0 CA--C 1.563 1.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.06 98.4 2.57 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 m -105.03 -54.64 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.077 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 61.64 3.78 0.92 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 121.121 1.782 . . . . 0.0 115.299 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 m170 67.19 117.01 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 128.977 2.911 . . . . 0.0 114.673 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.24 54.2 3.31 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 111.782 -2.463 . . . . 0.0 113.325 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -97.31 -59.98 1.67 Allowed 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -169.1 -10.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 12' ' ' ALA . 2.3 t -78.24 126.94 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 125.913 2.768 . . . . 0.0 117.991 -171.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.62 -5.26 32.16 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-N 109.826 -3.352 . . . . 0.0 113.586 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.583 ' H ' HG12 ' A' ' 9' ' ' VAL . 30.4 p90 -130.79 18.1 5.16 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.003 2.121 . . . . 0.0 113.647 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.658 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -143.49 -105.54 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 121.254 1.843 . . . . 0.0 115.676 -175.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.99 12.56 4.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -83.63 20.58 1.38 Allowed 'General case' 0 N--CA 1.517 2.881 0 O-C-N 119.424 -2.048 . . . . 0.0 113.611 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p 168.47 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 C-N-CA 131.641 3.976 . . . . 0.0 107.624 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.59 61.79 0.54 Allowed Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.678 1.581 . . . . 0.0 111.209 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t 51.18 25.56 2.48 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -106.12 107.04 17.84 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-N 123.027 2.649 . . . . 0.0 107.272 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -57.35 -32.81 67.11 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.42 -45.86 44.51 Favored Glycine 0 CA--C 1.563 3.086 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 71.11 106.08 0.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.492 2.317 . . . . 0.0 116.624 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.77 -38.12 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.389 0 CA-C-N 111.879 -2.419 . . . . 0.0 106.519 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mt -124.62 76.21 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.978 0 CA-C-N 119.84 1.2 . . . . 0.0 108.942 177.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.91 58.37 0.05 OUTLIER Glycine 0 N--CA 1.493 2.466 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.485 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -45.14 121.59 2.94 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 122.052 0.93 . . . . 0.0 110.804 -179.377 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt . . . . . 0 CA--C 1.567 1.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.57 0.91 0.3 Allowed 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 12' ' ' ALA . 12.3 t -68.27 99.06 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 CA-C-N 123.569 2.895 . . . . 0.0 118.293 -171.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -89.96 -14.15 34.69 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 129.068 2.947 . . . . 0.0 115.057 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -112.26 -1.67 15.09 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -149.27 -90.3 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -130.07 9.81 5.33 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 121.042 3.719 . . . . 0.0 121.042 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.51 31.93 0.66 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.253 2.297 . . . . 0.0 110.217 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p 158.16 -27.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 C-N-CA 129.599 3.159 . . . . 0.0 109.855 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.23 66.35 0.79 Allowed Glycine 0 N--CA 1.49 2.247 0 CA-C-N 122.68 2.491 . . . . 0.0 109.159 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.9 m 49.12 49.0 20.27 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 118.097 2.628 . . . . 0.0 118.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -174.44 70.77 0.03 OUTLIER 'General case' 0 CA--C 1.577 2.005 0 O-C-N 119.396 -2.065 . . . . 0.0 110.372 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 57.72 4.51 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.721 -1.862 . . . . 0.0 108.665 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 3.454 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -171.003 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.512 2.653 0 N-CA-C 118.068 2.618 . . . . 0.0 118.068 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -69.85 -9.27 54.16 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 12' ' ' ALA . 41.7 t -56.45 123.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-O 124.013 1.863 . . . . 0.0 115.983 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -115.86 -3.18 12.21 Favored 'General case' 0 CA--C 1.585 2.298 0 C-N-CA 130.748 3.619 . . . . 0.0 113.756 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.78 -3.47 6.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -176.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -141.95 -102.27 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.91 10.19 5.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.41 44.86 1.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 122.503 2.411 . . . . 0.0 108.132 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p 150.68 -33.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 C-N-CA 130.39 3.476 . . . . 0.0 109.311 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 58.81 0.84 Allowed Glycine 0 N--CA 1.49 2.29 0 CA-C-N 121.819 2.1 . . . . 0.0 111.992 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m 54.01 44.42 29.35 Favored 'General case' 0 CA--C 1.59 2.497 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.59 63.27 0.05 Allowed 'General case' 0 CA--C 1.583 2.241 0 O-C-N 119.081 -2.262 . . . . 0.0 113.284 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -83.73 66.28 8.96 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 118.502 -2.624 . . . . 0.0 109.002 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.633 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -171.433 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 tp -65.91 -53.89 33.5 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.984 2.629 . . . . 0.0 117.425 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 12' ' ' ALA . 39.3 t -40.28 130.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 126.386 2.993 . . . . 0.0 116.572 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.04 7.59 7.29 Favored 'General case' 0 CA--C 1.584 2.252 1 CA-C-N 107.775 -4.284 . . . . 0.0 114.563 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -128.74 -43.61 1.37 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.81 2.044 . . . . 0.0 113.389 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -98.54 -95.32 0.23 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -136.72 14.61 3.14 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 120.329 3.455 . . . . 0.0 120.329 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.415 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 1.8 m-20 -85.23 23.81 1.22 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 122.5 2.409 . . . . 0.0 110.672 173.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 p 168.05 -27.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 C-N-CA 131.185 3.794 . . . . 0.0 109.445 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.49 70.74 1.14 Allowed Glycine 0 N--CA 1.49 2.295 0 CA-C-N 122.944 2.611 . . . . 0.0 111.11 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m 51.54 39.41 24.7 Favored 'General case' 0 CA--C 1.592 2.592 0 N-CA-C 119.936 3.31 . . . . 0.0 119.936 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -173.78 78.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 118.693 -2.504 . . . . 0.0 111.643 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -104.65 70.43 0.94 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.595 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 pttm . . . . . 0 N--CA 1.513 2.678 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -97.96 3.07 49.61 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 119.037 2.977 . . . . 0.0 119.037 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 12' ' ' ALA . 3.7 t -72.72 94.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 N-CA-C 120.081 3.363 . . . . 0.0 120.081 -169.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -81.32 -23.08 38.05 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 128.648 2.779 . . . . 0.0 114.666 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -100.65 -16.91 17.26 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -139.72 -82.91 0.26 Allowed 'General case' 0 CA--C 1.555 1.158 1 N-CA-C 123.12 4.489 . . . . 0.0 123.12 -172.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -127.23 -1.12 6.39 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.481 3.882 . . . . 0.0 121.481 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.21 25.98 0.22 Allowed 'General case' 0 N--CA 1.521 3.109 0 CA-C-N 123.086 2.676 . . . . 0.0 111.898 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 p 164.91 -27.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.033 0 C-N-CA 129.642 3.177 . . . . 0.0 110.643 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.93 68.66 0.77 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 122.459 2.39 . . . . 0.0 108.074 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.1 m 46.03 45.78 12.39 Favored 'General case' 0 CA--C 1.593 2.612 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -171.39 72.34 0.05 OUTLIER 'General case' 0 CA--C 1.577 2.018 0 O-C-N 119.39 -2.069 . . . . 0.0 110.36 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.9 58.02 4.83 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 119.953 -1.717 . . . . 0.0 109.068 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.608 0 N-CA-C 105.968 -2.853 . . . . 0.0 105.968 -170.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.566 1.585 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -173.36 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 125.302 1.441 . . . . 0.0 111.817 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -16.25 101.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.589 2.453 0 C-N-CA 130.685 3.594 . . . . 0.0 118.067 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -100.45 -4.01 29.75 Favored 'General case' 0 CA--C 1.585 2.292 1 CA-C-N 107.562 -4.381 . . . . 0.0 114.01 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -119.8 -8.8 9.82 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 127.559 2.344 . . . . 0.0 116.133 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.94 -86.36 0.11 Allowed 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 119.412 3.115 . . . . 0.0 119.412 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -125.49 4.32 7.63 Favored 'General case' 0 N--CA 1.498 1.937 1 N-CA-C 122.591 4.293 . . . . 0.0 122.591 -172.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.81 9.11 4.48 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 121.77 2.077 . . . . 0.0 112.737 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p 176.51 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 C-N-CA 129.737 3.215 . . . . 0.0 111.335 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.68 58.73 0.89 Allowed Glycine 0 N--CA 1.494 2.529 0 CA-C-N 122.869 2.577 . . . . 0.0 109.789 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p 52.63 50.6 17.81 Favored 'General case' 0 CA--C 1.589 2.468 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -173.7 68.82 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.902 0 O-C-N 119.566 -1.959 . . . . 0.0 110.384 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.76 59.99 3.34 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.802 -1.811 . . . . 0.0 108.463 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.151 0 N-CA-C 106.368 -2.693 . . . . 0.0 106.368 -172.688 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.0 tttp . . . . . 0 CA--C 1.567 1.61 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.54 -43.47 0.19 Allowed 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 t -25.48 105.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.591 2.537 0 CA-C-O 127.292 3.425 . . . . 0.0 116.77 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -106.41 7.06 30.91 Favored 'General case' 0 CA--C 1.577 2.001 2 CA-C-N 107.077 -4.601 . . . . 0.0 114.658 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -130.6 -57.39 1.06 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 125.933 1.693 . . . . 0.0 113.12 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.08 -80.62 0.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -149.12 12.93 0.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 120.966 3.691 . . . . 0.0 120.966 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -85.68 39.09 0.78 Allowed 'General case' 0 N--CA 1.516 2.83 0 CA-C-N 122.543 2.429 . . . . 0.0 108.671 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p 152.43 -28.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.091 0 C-N-CA 130.63 3.572 . . . . 0.0 109.021 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.16 55.43 3.1 Favored Glycine 0 N--CA 1.491 2.365 0 CA-C-N 122.685 2.493 . . . . 0.0 109.596 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m 63.6 95.38 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.155 1.382 . . . . 0.0 112.648 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 149.52 47.77 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.139 0 C-N-CA 127.4 2.28 . . . . 0.0 111.239 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 63.4 3.22 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 117.206 -3.434 . . . . 0.0 103.737 175.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.58 4.103 0 N-CA-C 105.524 -3.03 . . . . 0.0 105.524 -169.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 tptt . . . . . 0 CA--C 1.574 1.899 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 pp -142.9 1.69 1.3 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 119.201 3.038 . . . . 0.0 119.201 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 12' ' ' ALA . 45.1 t -57.58 99.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.249 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -91.58 -0.17 57.56 Favored 'General case' 0 CA--C 1.58 2.123 0 C-N-CA 128.979 2.912 . . . . 0.0 115.123 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -122.7 -36.01 2.97 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -110.66 -99.93 0.4 Allowed 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 119.997 3.332 . . . . 0.0 119.997 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.49 14.42 4.51 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -82.81 20.28 1.19 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 122.288 2.313 . . . . 0.0 112.421 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 p 169.13 -24.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.035 0 C-N-CA 130.314 3.446 . . . . 0.0 109.581 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.92 69.55 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-N 123.012 2.642 . . . . 0.0 109.339 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 m 50.51 46.24 25.66 Favored 'General case' 0 CA--C 1.595 2.677 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -174.11 72.42 0.03 OUTLIER 'General case' 0 CA--C 1.581 2.162 0 O-C-N 118.797 -2.44 . . . . 0.0 111.01 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -88.52 65.08 7.73 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 119.509 -1.995 . . . . 0.0 108.581 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.686 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -172.114 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 123.318 1.533 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tp -159.32 -56.55 0.06 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.822 -1.174 . . . . 0.0 111.368 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 12' ' ' ALA . 42.5 t -51.13 103.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 126.864 3.221 . . . . 0.0 117.405 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -88.56 -9.5 52.06 Favored 'General case' 0 CA--C 1.577 2.007 0 CA-C-N 108.546 -3.934 . . . . 0.0 114.811 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -115.46 -14.89 11.54 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 127.191 2.196 . . . . 0.0 116.227 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.517 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -147.64 -70.5 0.23 Allowed 'General case' 0 CA--C 1.562 1.44 1 N-CA-C 124.291 4.923 . . . . 0.0 124.291 -174.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -129.52 -17.56 3.68 Favored 'General case' 0 N--CA 1.504 2.241 1 N-CA-C 126.967 5.914 . . . . 0.0 126.967 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.2 27.7 0.67 Allowed 'General case' 0 N--CA 1.52 3.055 0 CA-C-N 123.806 3.003 . . . . 0.0 111.549 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p 176.45 -32.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 C-N-CA 128.902 2.881 . . . . 0.0 110.66 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.92 65.18 0.79 Allowed Glycine 0 N--CA 1.489 2.17 0 CA-C-N 121.766 2.076 . . . . 0.0 110.558 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m 50.91 45.9 26.94 Favored 'General case' 0 CA--C 1.586 2.354 0 N-CA-C 117.884 2.55 . . . . 0.0 117.884 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -173.17 74.14 0.04 OUTLIER 'General case' 0 CA--C 1.576 1.949 0 O-C-N 119.669 -1.894 . . . . 0.0 111.094 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.71 62.78 3.29 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 119.942 -1.724 . . . . 0.0 107.454 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.477 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 -171.745 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.85 -52.64 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.069 0.948 . . . . 0.0 112.38 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 12' ' ' ALA . 9.6 t -53.44 148.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 CA-C-O 124.674 2.178 . . . . 0.0 115.682 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 -51.15 2.21 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 111.215 -2.721 . . . . 0.0 109.725 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -91.72 10.41 28.46 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.693 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -138.32 -109.52 0.17 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 123.696 2.953 . . . . 0.0 116.688 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -125.88 17.53 7.96 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.89 1.66 55.33 Favored 'General case' 0 CA--C 1.599 2.843 0 O-C-N 119.82 -1.8 . . . . 0.0 110.351 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 m -151.48 -40.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.904 0 C-N-CA 129.301 3.04 . . . . 0.0 110.085 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.85 62.31 0.56 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.93 1.241 . . . . 0.0 114.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.5 t 35.54 45.84 0.26 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 119.612 3.19 . . . . 0.0 119.612 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -101.65 -1.58 32.36 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.3 pttt 67.44 -49.99 0.5 Allowed 'General case' 0 N--CA 1.515 2.81 0 C-N-CA 128.059 2.544 . . . . 0.0 112.032 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 2.883 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.6 175.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptt . . . . . 0 N--CA 1.507 2.396 0 CA-C-O 122.168 0.985 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -164.13 -52.92 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 124.394 1.078 . . . . 0.0 112.639 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.37 152.4 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.092 0 CA-C-O 126.293 2.949 . . . . 0.0 116.452 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 -66.43 1.0 Allowed 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 109.845 -3.343 . . . . 0.0 108.138 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.64 7.98 2.66 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.12 -94.14 0.05 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.715 2.857 . . . . 0.0 118.715 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -98.87 7.26 46.23 Favored 'General case' 0 N--CA 1.496 1.835 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -171.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.74 30.25 4.09 Favored 'General case' 0 N--CA 1.517 2.898 0 CA-C-N 121.355 1.889 . . . . 0.0 109.451 172.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 p 176.54 -39.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 126.986 2.114 . . . . 0.0 112.11 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 63.63 0.57 Allowed Glycine 0 CA--C 1.55 2.231 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t 50.49 56.67 7.59 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 119.398 3.111 . . . . 0.0 119.398 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.91 -54.24 4.34 Favored 'General case' 0 CA--C 1.579 2.086 0 CA-C-N 121.629 2.013 . . . . 0.0 112.431 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 117.89 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 129.872 3.269 . . . . 0.0 107.852 -175.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.699 0 CA-C-O 117.971 -1.461 . . . . 0.0 113.766 174.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -176.61 -8.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 12' ' ' ALA . 2.2 t -75.06 138.74 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 CA-C-O 126.081 2.848 . . . . 0.0 116.824 -171.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.17 -35.01 5.76 Favored 'General case' 0 CA--C 1.579 2.073 0 CA-C-N 109.157 -3.656 . . . . 0.0 110.369 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -98.44 20.86 11.98 Favored 'General case' 0 CA--C 1.589 2.462 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.786 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -146.75 -104.91 0.09 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 121.928 2.149 . . . . 0.0 115.287 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -128.07 6.65 5.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -83.73 17.22 2.37 Favored 'General case' 0 CA--C 1.606 3.125 0 O-C-N 120.191 -1.568 . . . . 0.0 111.64 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.54 -42.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 C-N-CA 129.697 3.199 . . . . 0.0 108.698 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.82 50.23 0.36 Allowed Glycine 0 N--CA 1.486 1.997 0 CA-C-N 119.34 0.973 . . . . 0.0 114.712 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t 49.27 36.33 9.2 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 120.651 3.575 . . . . 0.0 120.651 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -4.64 59.2 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 123.475 2.852 . . . . 0.0 114.088 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.81 10.29 0.36 Allowed 'General case' 0 N--CA 1.525 3.294 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.564 0 C-N-CA 127.628 2.537 . . . . 0.0 109.548 178.593 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.81 -11.53 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 12' ' ' ALA . 46.1 t -77.33 131.18 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.057 0 CA-C-O 125.918 2.771 . . . . 0.0 116.063 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.43 -57.81 1.99 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 109.762 -3.381 . . . . 0.0 109.875 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.97 -8.12 55.58 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.459 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -140.45 -99.38 0.15 Allowed 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 121.655 3.946 . . . . 0.0 121.655 -175.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -106.28 5.47 29.77 Favored 'General case' 0 N--CA 1.5 2.064 1 N-CA-C 123.525 4.639 . . . . 0.0 123.525 -170.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.5 7.81 18.62 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 122.086 2.221 . . . . 0.0 112.489 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -171.55 -23.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.04 0 C-N-CA 127.983 2.513 . . . . 0.0 111.743 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.9 66.51 0.83 Allowed Glycine 0 N--CA 1.494 2.516 0 CA-C-N 122.85 2.568 . . . . 0.0 109.644 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 m 47.97 32.31 2.79 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -100.15 93.29 5.64 Favored 'General case' 0 CA--C 1.563 1.453 0 O-C-N 119.825 -1.797 . . . . 0.0 107.15 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 67.44 0.22 Allowed 'General case' 0 CA--C 1.573 1.85 0 CA-C-O 124.641 2.162 . . . . 0.0 114.649 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.563 0 CA-C-N 113.288 -1.778 . . . . 0.0 116.177 -179.223 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.59 -8.49 0.14 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 14' ' ' ASP . 50.1 t -69.17 130.55 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.322 0 CA-C-O 126.281 2.944 . . . . 0.0 115.782 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -111.91 -54.68 2.59 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 109.923 -3.308 . . . . 0.0 109.024 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -74.16 -7.74 53.69 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.22 -104.22 0.18 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -107.57 4.81 26.38 Favored 'General case' 0 N--CA 1.501 2.102 1 N-CA-C 122.089 4.107 . . . . 0.0 122.089 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.416 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 99.6 m-20 -89.5 11.41 19.51 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 121.448 1.931 . . . . 0.0 111.382 172.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -164.67 -36.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 127.38 2.272 . . . . 0.0 111.34 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.73 63.88 0.6 Allowed Glycine 0 N--CA 1.495 2.574 0 CA-C-N 121.006 1.73 . . . . 0.0 111.952 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 m 39.74 49.25 2.08 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 121.137 3.754 . . . . 0.0 121.137 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.13 -22.79 33.24 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 119.725 -1.86 . . . . 0.0 112.85 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt 54.59 35.22 23.06 Favored 'General case' 0 N--CA 1.52 3.039 0 CA-C-O 124.239 1.971 . . . . 0.0 113.473 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.794 0 C-N-CA 128.18 2.8 . . . . 0.0 110.353 -178.658 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.9 tptm . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.02 -10.12 12.9 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 12' ' ' ALA . 15.1 t -69.44 134.72 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.039 0 CA-C-N 124.508 3.322 . . . . 0.0 115.679 -172.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.6 -50.83 2.19 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 127.202 2.201 . . . . 0.0 109.901 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -80.55 -0.31 37.09 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -137.64 -109.11 0.18 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 118.034 2.605 . . . . 0.0 118.034 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.07 15.46 26.38 Favored 'General case' 0 N--CA 1.497 1.915 1 N-CA-C 121.839 4.014 . . . . 0.0 121.839 -172.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.21 11.08 26.86 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 121.686 2.039 . . . . 0.0 110.889 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -171.51 -29.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 C-N-CA 128.436 2.694 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.87 63.26 0.75 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 121.807 2.094 . . . . 0.0 110.42 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m 42.77 46.68 4.54 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -82.19 -23.97 35.21 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 119.228 -2.17 . . . . 0.0 114.135 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.61 33.89 17.45 Favored 'General case' 0 N--CA 1.523 3.216 0 CA-C-N 121.966 2.166 . . . . 0.0 114.566 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.732 0 C-N-CA 128.143 2.782 . . . . 0.0 108.605 -178.839 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt . . . . . 0 CA--C 1.567 1.614 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -169.1 -10.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 12' ' ' ALA . 2.3 t -78.24 126.94 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 125.913 2.768 . . . . 0.0 117.991 -171.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.62 -5.26 32.16 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-N 109.826 -3.352 . . . . 0.0 113.586 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.583 ' H ' HG12 ' A' ' 9' ' ' VAL . 30.4 p90 -130.79 18.1 5.16 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.003 2.121 . . . . 0.0 113.647 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.658 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -143.49 -105.54 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 121.254 1.843 . . . . 0.0 115.676 -175.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.99 12.56 4.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -83.63 20.58 1.38 Allowed 'General case' 0 N--CA 1.517 2.881 0 O-C-N 119.424 -2.048 . . . . 0.0 113.611 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p 168.47 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 C-N-CA 131.641 3.976 . . . . 0.0 107.624 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.59 61.79 0.54 Allowed Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.678 1.581 . . . . 0.0 111.209 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t 51.18 25.56 2.48 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -106.12 107.04 17.84 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-N 123.027 2.649 . . . . 0.0 107.272 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -57.35 -32.81 67.11 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 3.086 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 173.559 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 64.9 t80 . . . . . 0 CA--C 1.566 1.593 0 CA-C-O 121.628 0.727 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -84.3 -14.8 48.75 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t 69.42 -51.99 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 C-N-CA 126.678 1.991 . . . . 0.0 112.911 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.1 m170 71.53 -34.19 0.29 Allowed 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.258 1.823 . . . . 0.0 112.894 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 m80 64.43 162.46 0.12 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.592 1.957 . . . . 0.0 116.136 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 44.03 42.24 4.64 Favored 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 129.317 3.047 . . . . 0.0 117.693 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -138.08 -64.68 0.53 Allowed 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -152.57 0.91 0.3 Allowed 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 12' ' ' ALA . 12.3 t -68.27 99.06 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 CA-C-N 123.569 2.895 . . . . 0.0 118.293 -171.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -89.96 -14.15 34.69 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 129.068 2.947 . . . . 0.0 115.057 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -112.26 -1.67 15.09 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -149.27 -90.3 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -130.07 9.81 5.33 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 121.042 3.719 . . . . 0.0 121.042 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.51 31.93 0.66 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.253 2.297 . . . . 0.0 110.217 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p 158.16 -27.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 C-N-CA 129.599 3.159 . . . . 0.0 109.855 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.23 66.35 0.79 Allowed Glycine 0 N--CA 1.49 2.247 0 CA-C-N 122.68 2.491 . . . . 0.0 109.159 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.9 m 49.12 49.0 20.27 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 118.097 2.628 . . . . 0.0 118.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -174.44 70.77 0.03 OUTLIER 'General case' 0 CA--C 1.577 2.005 0 O-C-N 119.396 -2.065 . . . . 0.0 110.372 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 57.72 4.51 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.721 -1.862 . . . . 0.0 108.665 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.59 51.32 59.41 Favored Glycine 0 CA--C 1.569 3.454 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -171.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.257 . . -147.49 -37.28 0.21 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 121.233 3.79 . . . . 0.0 121.233 -170.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 mp 58.03 36.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.618 3.579 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mt 68.63 90.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 1.992 0 C-N-CA 127.997 2.519 . . . . 0.0 108.531 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 174.69 -91.3 0.08 OUTLIER Glycine 0 N--CA 1.484 1.869 0 O-C-N 121.585 -0.697 . . . . 0.0 112.779 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -143.7 162.58 35.6 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.727 0.775 . . . . 0.0 111.499 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 123.746 1.736 . . . . 0.0 110.9 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.1 t80 . . . . . 0 CA--C 1.564 1.496 0 CA-C-O 121.336 0.589 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -79.38 0.4 Allowed 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 p -149.91 89.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -87.27 66.89 9.4 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 103.198 -2.89 . . . . 0.0 103.198 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -5.21 115.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 119.742 3.238 . . . . 0.0 119.742 -172.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.64 -92.94 0.14 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 115.44 -2.219 . . . . 0.0 109.201 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -165.74 -39.62 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 CA-C-N 123.67 2.941 . . . . 0.0 118.068 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -69.85 -9.27 54.16 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 12' ' ' ALA . 41.7 t -56.45 123.37 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-O 124.013 1.863 . . . . 0.0 115.983 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -115.86 -3.18 12.21 Favored 'General case' 0 CA--C 1.585 2.298 0 C-N-CA 130.748 3.619 . . . . 0.0 113.756 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.78 -3.47 6.54 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -176.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -141.95 -102.27 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.91 10.19 5.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.41 44.86 1.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 122.503 2.411 . . . . 0.0 108.132 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p 150.68 -33.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 C-N-CA 130.39 3.476 . . . . 0.0 109.311 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 58.81 0.84 Allowed Glycine 0 N--CA 1.49 2.29 0 CA-C-N 121.819 2.1 . . . . 0.0 111.992 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m 54.01 44.42 29.35 Favored 'General case' 0 CA--C 1.59 2.497 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.59 63.27 0.05 Allowed 'General case' 0 CA--C 1.583 2.241 0 O-C-N 119.081 -2.262 . . . . 0.0 113.284 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -83.73 66.28 8.96 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 118.502 -2.624 . . . . 0.0 109.002 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.26 46.51 79.1 Favored Glycine 0 N--CA 1.51 3.633 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -171.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.267 . . -142.51 -52.53 0.4 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 121.33 3.826 . . . . 0.0 121.33 -169.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 mm 61.89 32.92 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.608 3.202 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mt 64.9 81.58 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.075 0 C-N-CA 126.758 2.023 . . . . 0.0 108.498 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.53 -50.72 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 119.072 2.389 . . . . 0.0 119.072 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.2 tp -138.93 120.42 15.01 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 119.239 1.519 . . . . 0.0 110.469 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 124.364 2.031 . . . . 0.0 111.813 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 17.1 t80 . . . . . 0 CA--C 1.566 1.573 0 CA-C-O 121.851 0.834 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -102.58 81.24 2.01 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-O 122.919 1.342 . . . . 0.0 108.38 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 t -58.05 106.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.535 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -86.56 78.77 9.12 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -29.53 133.17 0.05 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 120.892 3.664 . . . . 0.0 120.892 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.43 -85.31 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 117.538 -1.22 . . . . 0.0 111.077 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.45 -20.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 tp -65.91 -53.89 33.5 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.984 2.629 . . . . 0.0 117.425 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 12' ' ' ALA . 39.3 t -40.28 130.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 126.386 2.993 . . . . 0.0 116.572 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.04 7.59 7.29 Favored 'General case' 0 CA--C 1.584 2.252 1 CA-C-N 107.775 -4.284 . . . . 0.0 114.563 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -128.74 -43.61 1.37 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.81 2.044 . . . . 0.0 113.389 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -98.54 -95.32 0.23 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -136.72 14.61 3.14 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 120.329 3.455 . . . . 0.0 120.329 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 1.8 m-20 -85.23 23.81 1.22 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 122.5 2.409 . . . . 0.0 110.672 173.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 p 168.05 -27.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 C-N-CA 131.185 3.794 . . . . 0.0 109.445 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.49 70.74 1.14 Allowed Glycine 0 N--CA 1.49 2.295 0 CA-C-N 122.944 2.611 . . . . 0.0 111.11 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m 51.54 39.41 24.7 Favored 'General case' 0 CA--C 1.592 2.592 0 N-CA-C 119.936 3.31 . . . . 0.0 119.936 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -173.78 78.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 118.693 -2.504 . . . . 0.0 111.643 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -104.65 70.43 0.94 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 57.25 52.45 51.45 Favored Glycine 0 N--CA 1.51 3.595 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.253 . . -152.8 -50.96 0.1 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 120.974 3.694 . . . . 0.0 120.974 -170.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mp 58.94 31.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.613 3.378 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.8 mt 62.84 71.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 119.226 -2.171 . . . . 0.0 107.11 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.05 -24.84 0.12 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 121.4 3.32 . . . . 0.0 121.4 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.3 -87.3 0.47 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 121.802 2.801 . . . . 0.0 105.801 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 123.682 1.706 . . . . 0.0 108.295 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 CA--C 1.57 1.718 0 CA-C-O 117.722 -1.132 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -150.5 -56.83 0.17 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 121.3 1.864 . . . . 0.0 112.839 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 9' ' ' VAL . 7.7 m -41.75 121.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 123.661 1.696 . . . . 0.0 114.667 -176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -121.25 90.85 3.4 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.457 ' H ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER 91.46 170.22 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 129.75 3.22 . . . . 0.0 109.655 -178.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 122.52 -73.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 128.953 2.901 . . . . 0.0 106.424 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -153.99 -46.68 0.09 Allowed 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -97.96 3.07 49.61 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 119.037 2.977 . . . . 0.0 119.037 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.462 HG22 HG23 ' A' ' 3' ' ' VAL . 3.7 t -72.72 94.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 N-CA-C 120.081 3.363 . . . . 0.0 120.081 -169.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -81.32 -23.08 38.05 Favored 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 128.648 2.779 . . . . 0.0 114.666 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -100.65 -16.91 17.26 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -139.72 -82.91 0.26 Allowed 'General case' 0 CA--C 1.555 1.158 1 N-CA-C 123.12 4.489 . . . . 0.0 123.12 -172.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -127.23 -1.12 6.39 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.481 3.882 . . . . 0.0 121.481 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.21 25.98 0.22 Allowed 'General case' 0 N--CA 1.521 3.109 0 CA-C-N 123.086 2.676 . . . . 0.0 111.898 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 p 164.91 -27.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.033 0 C-N-CA 129.642 3.177 . . . . 0.0 110.643 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.93 68.66 0.77 Allowed Glycine 0 N--CA 1.492 2.427 0 CA-C-N 122.459 2.39 . . . . 0.0 108.074 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.1 m 46.03 45.78 12.39 Favored 'General case' 0 CA--C 1.593 2.612 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -171.39 72.34 0.05 OUTLIER 'General case' 0 CA--C 1.577 2.018 0 O-C-N 119.39 -2.069 . . . . 0.0 110.36 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.9 58.02 4.83 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 119.953 -1.717 . . . . 0.0 109.068 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.25 54.64 36.25 Favored Glycine 0 N--CA 1.51 3.608 0 N-CA-C 105.968 -2.853 . . . . 0.0 105.968 -170.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.266 . . -147.51 -39.54 0.19 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 121.762 3.986 . . . . 0.0 121.762 -169.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mm 61.79 26.16 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.614 3.425 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -172.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mt 69.72 81.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 C-N-CA 127.449 2.3 . . . . 0.0 107.723 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.08 -56.68 0.44 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 115.713 1.045 . . . . 0.0 115.713 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.8 mt -87.92 179.47 6.44 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 117.833 0.816 . . . . 0.0 111.986 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 123.996 1.855 . . . . 0.0 108.808 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 21.5 t80 . . . . . 0 CA--C 1.563 1.456 0 CA-C-O 121.309 0.576 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.38 -41.82 6.88 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.5 m -77.79 87.43 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 123.031 1.396 . . . . 0.0 110.966 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -84.63 74.99 10.34 Favored 'General case' 0 CA--C 1.581 2.147 0 O-C-N 120.008 -1.683 . . . . 0.0 109.936 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.8 m80 1.07 132.64 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.118 1 N-CA-C 123.752 4.723 . . . . 0.0 123.752 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 67.82 68.41 0.35 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 129.167 2.987 . . . . 0.0 111.477 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.01 -53.43 1.74 Allowed 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 113.291 -1.777 . . . . 0.0 112.411 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -173.36 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 125.302 1.441 . . . . 0.0 111.817 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 t -16.25 101.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.589 2.453 0 C-N-CA 130.685 3.594 . . . . 0.0 118.067 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -100.45 -4.01 29.75 Favored 'General case' 0 CA--C 1.585 2.292 1 CA-C-N 107.562 -4.381 . . . . 0.0 114.01 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -119.8 -8.8 9.82 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 127.559 2.344 . . . . 0.0 116.133 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.94 -86.36 0.11 Allowed 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 119.412 3.115 . . . . 0.0 119.412 -175.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -125.49 4.32 7.63 Favored 'General case' 0 N--CA 1.498 1.937 1 N-CA-C 122.591 4.293 . . . . 0.0 122.591 -172.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.81 9.11 4.48 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 121.77 2.077 . . . . 0.0 112.737 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p 176.51 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 C-N-CA 129.737 3.215 . . . . 0.0 111.335 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.68 58.73 0.89 Allowed Glycine 0 N--CA 1.494 2.529 0 CA-C-N 122.869 2.577 . . . . 0.0 109.789 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p 52.63 50.6 17.81 Favored 'General case' 0 CA--C 1.589 2.468 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -173.7 68.82 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.902 0 O-C-N 119.566 -1.959 . . . . 0.0 110.384 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.76 59.99 3.34 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.802 -1.811 . . . . 0.0 108.463 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.2 57.41 15.54 Favored Glycine 0 N--CA 1.503 3.151 0 N-CA-C 106.368 -2.693 . . . . 0.0 106.368 -172.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.22 -41.17 0.09 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 120.586 3.55 . . . . 0.0 120.586 -171.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.8 mm 60.03 29.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.613 3.378 0 CA-C-N 119.622 1.101 . . . . 0.0 108.263 -172.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 mt 70.0 86.24 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 C-N-CA 127.389 2.275 . . . . 0.0 107.861 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.51 -81.29 0.07 OUTLIER Glycine 0 N--CA 1.485 1.933 0 O-C-N 121.262 -0.899 . . . . 0.0 114.68 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 pp -136.92 164.05 29.23 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.169 0.985 . . . . 0.0 112.271 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 35.2 mmt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 123.505 1.621 . . . . 0.0 110.154 179.445 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 CA--C 1.562 1.433 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.82 78.02 1.77 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.306 1.051 . . . . 0.0 108.519 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -86.05 114.2 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.87 -1.144 . . . . 0.0 108.288 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -66.12 -20.34 66.12 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.4 m80 61.13 165.62 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.453 2.019 . . . . 0.0 116.453 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 42.47 42.28 2.64 Favored 'General case' 0 CA--C 1.577 2.014 0 C-N-CA 129.283 3.033 . . . . 0.0 118.268 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -138.05 -61.94 0.6 Allowed 'General case' 0 CA--C 1.567 1.61 0 O-C-N 121.078 -1.014 . . . . 0.0 113.223 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.54 -43.47 0.19 Allowed 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 t -25.48 105.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.591 2.537 0 CA-C-O 127.292 3.425 . . . . 0.0 116.77 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -106.41 7.06 30.91 Favored 'General case' 0 CA--C 1.577 2.001 2 CA-C-N 107.077 -4.601 . . . . 0.0 114.658 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -130.6 -57.39 1.06 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 125.933 1.693 . . . . 0.0 113.12 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.08 -80.62 0.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -149.12 12.93 0.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 120.966 3.691 . . . . 0.0 120.966 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -85.68 39.09 0.78 Allowed 'General case' 0 N--CA 1.516 2.83 0 CA-C-N 122.543 2.429 . . . . 0.0 108.671 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p 152.43 -28.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.091 0 C-N-CA 130.63 3.572 . . . . 0.0 109.021 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.16 55.43 3.1 Favored Glycine 0 N--CA 1.491 2.365 0 CA-C-N 122.685 2.493 . . . . 0.0 109.596 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m 63.6 95.38 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.155 1.382 . . . . 0.0 112.648 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 149.52 47.77 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.139 0 C-N-CA 127.4 2.28 . . . . 0.0 111.239 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 63.4 3.22 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 117.206 -3.434 . . . . 0.0 103.737 175.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.15 -57.22 4.79 Favored Glycine 1 CA--C 1.58 4.103 0 N-CA-C 105.524 -3.03 . . . . 0.0 105.524 -169.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.31 117.31 25.03 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.84 2.856 . . . . 0.0 115.234 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.52 65.61 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.225 0 N-CA-C 102.764 -3.05 . . . . 0.0 102.764 172.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.2 mt 71.25 86.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.581 2.136 0 C-N-CA 126.526 1.931 . . . . 0.0 106.825 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -177.51 -103.33 0.17 Allowed Glycine 0 N--CA 1.487 2.05 0 O-C-N 121.098 -1.001 . . . . 0.0 115.44 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -141.17 149.84 41.98 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.652 1.215 . . . . 0.0 112.281 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 124.869 2.271 . . . . 0.0 112.65 -179.46 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 38.8 t80 . . . . . 0 CA--C 1.567 1.632 0 CA-C-O 121.812 0.815 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -68.88 -32.55 72.28 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t 70.54 -50.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 C-N-CA 126.09 1.756 . . . . 0.0 111.717 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 70.36 -34.61 0.3 Allowed 'General case' 0 N--CA 1.515 2.799 0 CA-C-N 121.42 1.918 . . . . 0.0 113.318 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.3 m80 70.3 148.19 0.07 Allowed 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 127.795 2.438 . . . . 0.0 116.472 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 64.81 72.79 0.43 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 129.626 3.17 . . . . 0.0 113.322 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -157.78 -88.19 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.899 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.708 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 pp -142.9 1.69 1.3 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 119.201 3.038 . . . . 0.0 119.201 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 12' ' ' ALA . 45.1 t -57.58 99.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.249 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -91.58 -0.17 57.56 Favored 'General case' 0 CA--C 1.58 2.123 0 C-N-CA 128.979 2.912 . . . . 0.0 115.123 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -122.7 -36.01 2.97 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -110.66 -99.93 0.4 Allowed 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 119.997 3.332 . . . . 0.0 119.997 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.49 14.42 4.51 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 120.641 3.571 . . . . 0.0 120.641 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -82.81 20.28 1.19 Allowed 'General case' 0 N--CA 1.519 3.003 0 CA-C-N 122.288 2.313 . . . . 0.0 112.421 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 p 169.13 -24.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.035 0 C-N-CA 130.314 3.446 . . . . 0.0 109.581 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.92 69.55 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-N 123.012 2.642 . . . . 0.0 109.339 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 m 50.51 46.24 25.66 Favored 'General case' 0 CA--C 1.595 2.677 0 N-CA-C 118.669 2.84 . . . . 0.0 118.669 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -174.11 72.42 0.03 OUTLIER 'General case' 0 CA--C 1.581 2.162 0 O-C-N 118.797 -2.44 . . . . 0.0 111.01 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -88.52 65.08 7.73 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 119.509 -1.995 . . . . 0.0 108.581 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 57.7 45.12 93.72 Favored Glycine 0 N--CA 1.511 3.686 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.61 -39.99 0.71 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 120.659 3.578 . . . . 0.0 120.659 -171.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 mp 75.0 -48.64 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.599 2.85 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 -173.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.0 tp 176.07 97.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.29 -42.44 1.42 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 121.368 3.307 . . . . 0.0 121.368 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.05 90.07 2.47 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 118.957 1.379 . . . . 0.0 113.511 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.1 mmt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 124.79 2.233 . . . . 0.0 112.582 -179.419 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 85.9 t80 . . . . . 0 CA--C 1.565 1.55 0 CA-C-O 121.025 0.44 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -151.91 90.33 1.53 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.59 119.22 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 119.932 -1.73 . . . . 0.0 107.218 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -83.92 72.07 10.45 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -98.01 149.11 22.8 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 125.544 1.538 . . . . 0.0 113.861 -175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.18 -54.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.417 1.087 . . . . 0.0 108.571 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.54 72.59 0.09 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 123.318 1.533 . . . . 0.0 108.622 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tp -159.32 -56.55 0.06 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.822 -1.174 . . . . 0.0 111.368 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 12' ' ' ALA . 42.5 t -51.13 103.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 126.864 3.221 . . . . 0.0 117.405 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -88.56 -9.5 52.06 Favored 'General case' 0 CA--C 1.577 2.007 0 CA-C-N 108.546 -3.934 . . . . 0.0 114.811 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -115.46 -14.89 11.54 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 127.191 2.196 . . . . 0.0 116.227 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.517 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -147.64 -70.5 0.23 Allowed 'General case' 0 CA--C 1.562 1.44 1 N-CA-C 124.291 4.923 . . . . 0.0 124.291 -174.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -129.52 -17.56 3.68 Favored 'General case' 0 N--CA 1.504 2.241 1 N-CA-C 126.967 5.914 . . . . 0.0 126.967 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.2 27.7 0.67 Allowed 'General case' 0 N--CA 1.52 3.055 0 CA-C-N 123.806 3.003 . . . . 0.0 111.549 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p 176.45 -32.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 C-N-CA 128.902 2.881 . . . . 0.0 110.66 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.92 65.18 0.79 Allowed Glycine 0 N--CA 1.489 2.17 0 CA-C-N 121.766 2.076 . . . . 0.0 110.558 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m 50.91 45.9 26.94 Favored 'General case' 0 CA--C 1.586 2.354 0 N-CA-C 117.884 2.55 . . . . 0.0 117.884 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -173.17 74.14 0.04 OUTLIER 'General case' 0 CA--C 1.576 1.949 0 O-C-N 119.669 -1.894 . . . . 0.0 111.094 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.71 62.78 3.29 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 119.942 -1.724 . . . . 0.0 107.454 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.85 51.89 56.44 Favored Glycine 0 N--CA 1.508 3.477 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 0.253 . . -147.7 -42.74 0.17 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 120.614 3.561 . . . . 0.0 120.614 -170.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.1 mp 57.86 35.99 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.614 3.42 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt 66.93 83.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 C-N-CA 127.337 2.255 . . . . 0.0 109.223 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.01 -65.57 0.3 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 118.163 2.025 . . . . 0.0 118.163 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 pp -102.62 -177.36 3.36 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 9.7 mmt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 123.865 1.793 . . . . 0.0 108.015 179.725 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 37.1 t80 . . . . . 0 CA--C 1.565 1.542 0 CA-C-O 121.603 0.716 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -65.93 -31.15 71.91 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 t 71.86 89.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 126.363 1.865 . . . . 0.0 107.401 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -84.53 74.15 10.44 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -34.21 117.28 0.33 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 119.994 3.331 . . . . 0.0 119.994 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.5 1.8 0.03 OUTLIER 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 117.997 2.592 . . . . 0.0 117.997 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt 84.92 87.05 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 127.286 2.234 . . . . 0.0 107.947 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.85 -52.64 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.069 0.948 . . . . 0.0 112.38 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 12' ' ' ALA . 9.6 t -53.44 148.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 CA-C-O 124.674 2.178 . . . . 0.0 115.682 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.3 -51.15 2.21 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 111.215 -2.721 . . . . 0.0 109.725 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -91.72 10.41 28.46 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 117.871 2.545 . . . . 0.0 117.871 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.693 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -138.32 -109.52 0.17 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 123.696 2.953 . . . . 0.0 116.688 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -125.88 17.53 7.96 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.855 2.909 . . . . 0.0 118.855 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.89 1.66 55.33 Favored 'General case' 0 CA--C 1.599 2.843 0 O-C-N 119.82 -1.8 . . . . 0.0 110.351 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 m -151.48 -40.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.904 0 C-N-CA 129.301 3.04 . . . . 0.0 110.085 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.85 62.31 0.56 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 119.93 1.241 . . . . 0.0 114.054 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.5 t 35.54 45.84 0.26 Allowed 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 119.612 3.19 . . . . 0.0 119.612 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -101.65 -1.58 32.36 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.3 pttt 67.44 -49.99 0.5 Allowed 'General case' 0 N--CA 1.515 2.81 0 C-N-CA 128.059 2.544 . . . . 0.0 112.032 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.48 -10.93 39.98 Favored Glycine 0 CA--C 1.56 2.883 0 CA-C-O 118.617 -1.102 . . . . 0.0 114.6 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.41 77.48 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.155 1.782 . . . . 0.0 114.385 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.8 mt -82.65 50.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.595 2.708 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.35 -61.65 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 O-C-N 120.554 -1.341 . . . . 0.0 108.097 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.03 67.06 0.05 OUTLIER Glycine 0 N--CA 1.485 1.936 0 CA-C-N 119.502 1.046 . . . . 0.0 112.984 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -153.07 -80.6 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.076 0.938 . . . . 0.0 110.037 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-N 119.897 1.226 . . . . 0.0 113.601 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 39.3 t80 . . . . . 0 CA--C 1.567 1.614 0 CA-C-O 122.37 1.081 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.91 92.4 2.6 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.81 120.88 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 O-C-N 120.939 -1.101 . . . . 0.0 110.387 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.8 103.95 15.91 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -131.08 -67.81 0.69 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.033 0.933 . . . . 0.0 109.718 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 54.78 62.14 2.66 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 127.716 2.406 . . . . 0.0 113.281 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 93.03 81.75 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 126.915 2.086 . . . . 0.0 111.274 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -164.13 -52.92 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 124.394 1.078 . . . . 0.0 112.639 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.37 152.4 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.092 0 CA-C-O 126.293 2.949 . . . . 0.0 116.452 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 -66.43 1.0 Allowed 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 109.845 -3.343 . . . . 0.0 108.138 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -74.64 7.98 2.66 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.12 -94.14 0.05 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.715 2.857 . . . . 0.0 118.715 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -98.87 7.26 46.23 Favored 'General case' 0 N--CA 1.496 1.835 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -171.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.74 30.25 4.09 Favored 'General case' 0 N--CA 1.517 2.898 0 CA-C-N 121.355 1.889 . . . . 0.0 109.451 172.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 p 176.54 -39.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 126.986 2.114 . . . . 0.0 112.11 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 63.63 0.57 Allowed Glycine 0 CA--C 1.55 2.231 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t 50.49 56.67 7.59 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 119.398 3.111 . . . . 0.0 119.398 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.91 -54.24 4.34 Favored 'General case' 0 CA--C 1.579 2.086 0 CA-C-N 121.629 2.013 . . . . 0.0 112.431 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 117.89 -29.89 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 129.872 3.269 . . . . 0.0 107.852 -175.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.03 -17.74 7.67 Favored Glycine 0 CA--C 1.557 2.699 0 CA-C-O 117.971 -1.461 . . . . 0.0 113.766 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.44 78.05 0.23 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 120.57 2.185 . . . . 0.0 111.303 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -80.9 63.62 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.372 0 CA-C-O 124.222 1.963 . . . . 0.0 105.903 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.3 mm -127.6 -58.18 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 C-N-CA 126.936 2.094 . . . . 0.0 105.73 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 167.04 58.78 0.03 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.79 -140.65 0.05 OUTLIER 'General case' 0 CA--C 1.582 2.18 0 CA-C-N 118.028 0.914 . . . . 0.0 108.78 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.981 0 O-C-N 118.577 -2.577 . . . . 0.0 115.24 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 17.3 p90 . . . . . 0 CA--C 1.566 1.572 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -148.83 -109.45 0.07 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.9 t 62.45 -41.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 67.14 82.6 0.18 Allowed 'General case' 0 N--CA 1.512 2.652 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -55.4 149.09 13.81 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 121.198 3.777 . . . . 0.0 121.198 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 65.38 75.27 0.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 110.385 -3.098 . . . . 0.0 113.025 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.65 -50.32 0.98 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.155 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -176.61 -8.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 12' ' ' ALA . 2.2 t -75.06 138.74 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 CA-C-O 126.081 2.848 . . . . 0.0 116.824 -171.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.17 -35.01 5.76 Favored 'General case' 0 CA--C 1.579 2.073 0 CA-C-N 109.157 -3.656 . . . . 0.0 110.369 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -98.44 20.86 11.98 Favored 'General case' 0 CA--C 1.589 2.462 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.786 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -146.75 -104.91 0.09 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 121.928 2.149 . . . . 0.0 115.287 -177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -128.07 6.65 5.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -83.73 17.22 2.37 Favored 'General case' 0 CA--C 1.606 3.125 0 O-C-N 120.191 -1.568 . . . . 0.0 111.64 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.54 -42.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.027 0 C-N-CA 129.697 3.199 . . . . 0.0 108.698 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.82 50.23 0.36 Allowed Glycine 0 N--CA 1.486 1.997 0 CA-C-N 119.34 0.973 . . . . 0.0 114.712 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t 49.27 36.33 9.2 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 120.651 3.575 . . . . 0.0 120.651 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -4.64 59.2 Favored 'General case' 0 CA--C 1.582 2.21 0 CA-C-N 123.475 2.852 . . . . 0.0 114.088 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.81 10.29 0.36 Allowed 'General case' 0 N--CA 1.525 3.294 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.95 -47.29 0.05 OUTLIER Glycine 0 CA--C 1.555 2.564 0 C-N-CA 127.628 2.537 . . . . 0.0 109.548 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 77.09 88.37 0.08 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.319 2.248 . . . . 0.0 113.907 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.8 mp -68.76 -34.23 63.62 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.537 0 CA-C-N 110.123 -3.217 . . . . 0.0 107.26 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.94 73.83 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.911 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.65 -50.0 0.25 Allowed Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.196 -0.94 . . . . 0.0 114.761 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 tm? 61.85 87.04 0.1 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 126.245 1.818 . . . . 0.0 112.99 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 122.865 1.317 . . . . 0.0 109.883 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 CA--C 1.578 2.051 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -87.85 -69.84 0.67 Allowed 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 119.91 1.232 . . . . 0.0 112.557 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.3 m -91.62 108.96 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 122.618 1.199 . . . . 0.0 110.755 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -92.79 53.34 2.01 Favored 'General case' 0 CA--C 1.579 2.079 0 O-C-N 120.823 -1.173 . . . . 0.0 110.011 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 18.13 94.88 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 119.84 3.274 . . . . 0.0 119.84 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.34 -75.08 0.6 Allowed 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.26 80.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.741 1.216 . . . . 0.0 107.768 177.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.81 -11.53 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 12' ' ' ALA . 46.1 t -77.33 131.18 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.057 0 CA-C-O 125.918 2.771 . . . . 0.0 116.063 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.43 -57.81 1.99 Allowed 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 109.762 -3.381 . . . . 0.0 109.875 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.97 -8.12 55.58 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.459 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -140.45 -99.38 0.15 Allowed 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 121.655 3.946 . . . . 0.0 121.655 -175.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -106.28 5.47 29.77 Favored 'General case' 0 N--CA 1.5 2.064 1 N-CA-C 123.525 4.639 . . . . 0.0 123.525 -170.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.5 7.81 18.62 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 122.086 2.221 . . . . 0.0 112.489 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -171.55 -23.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.04 0 C-N-CA 127.983 2.513 . . . . 0.0 111.743 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.9 66.51 0.83 Allowed Glycine 0 N--CA 1.494 2.516 0 CA-C-N 122.85 2.568 . . . . 0.0 109.644 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.5 m 47.97 32.31 2.79 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -100.15 93.29 5.64 Favored 'General case' 0 CA--C 1.563 1.453 0 O-C-N 119.825 -1.797 . . . . 0.0 107.15 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 67.44 0.22 Allowed 'General case' 0 CA--C 1.573 1.85 0 CA-C-O 124.641 2.162 . . . . 0.0 114.649 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.51 10.33 0.08 OUTLIER Glycine 0 CA--C 1.555 2.563 0 CA-C-N 113.288 -1.778 . . . . 0.0 116.177 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.82 -101.51 0.42 Allowed 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.1 mt 70.84 -76.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 tp -133.72 -13.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.311 0 C-N-CA 125.054 1.341 . . . . 0.0 112.319 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.11 65.51 0.47 Allowed Glycine 0 N--CA 1.49 2.27 0 CA-C-N 121.48 1.946 . . . . 0.0 113.498 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -150.35 -58.08 0.18 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.616 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -179.024 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 55.8 t80 . . . . . 0 CA--C 1.563 1.457 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -113.15 43.69 1.67 Allowed 'General case' 0 CA--C 1.581 2.173 0 CA-C-O 121.268 0.556 . . . . 0.0 111.827 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.22 104.27 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 119.783 -1.823 . . . . 0.0 108.46 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -91.25 74.79 6.17 Favored 'General case' 0 CA--C 1.577 2.007 0 CA-C-O 122.469 1.128 . . . . 0.0 108.081 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -27.11 145.06 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 121.67 3.952 . . . . 0.0 121.67 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 64.11 72.09 0.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 127.721 2.408 . . . . 0.0 108.86 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.6 -62.17 0.66 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.988 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.59 -8.49 0.14 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 14' ' ' ASP . 50.1 t -69.17 130.55 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.322 0 CA-C-O 126.281 2.944 . . . . 0.0 115.782 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -111.91 -54.68 2.59 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 109.923 -3.308 . . . . 0.0 109.024 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -74.16 -7.74 53.69 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.22 -104.22 0.18 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -107.57 4.81 26.38 Favored 'General case' 0 N--CA 1.501 2.102 1 N-CA-C 122.089 4.107 . . . . 0.0 122.089 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.416 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 99.6 m-20 -89.5 11.41 19.51 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 121.448 1.931 . . . . 0.0 111.382 172.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -164.67 -36.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 127.38 2.272 . . . . 0.0 111.34 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.73 63.88 0.6 Allowed Glycine 0 N--CA 1.495 2.574 0 CA-C-N 121.006 1.73 . . . . 0.0 111.952 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 m 39.74 49.25 2.08 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 121.137 3.754 . . . . 0.0 121.137 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.13 -22.79 33.24 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 119.725 -1.86 . . . . 0.0 112.85 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt 54.59 35.22 23.06 Favored 'General case' 0 N--CA 1.52 3.039 0 CA-C-O 124.239 1.971 . . . . 0.0 113.473 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.45 -39.83 0.08 OUTLIER Glycine 0 CA--C 1.559 2.794 0 C-N-CA 128.18 2.8 . . . . 0.0 110.353 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 67.88 83.52 0.16 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 126.529 1.932 . . . . 0.0 111.504 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.52 53.09 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.592 2.596 0 CA-C-N 112.83 -1.986 . . . . 0.0 105.738 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tp -119.35 -51.6 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 C-N-CA 125.194 1.398 . . . . 0.0 109.045 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.53 57.86 0.02 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 115.453 0.941 . . . . 0.0 115.453 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.31 -67.54 0.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 118.749 1.275 . . . . 0.0 109.915 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.5 mpp? . . . . . 0 N--CA 1.494 1.757 0 CA-C-N 120.761 1.619 . . . . 0.0 111.244 -179.558 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 56.8 t80 . . . . . 0 CA--C 1.565 1.526 0 CA-C-O 121.199 0.523 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -142.87 90.44 2.21 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 123.281 1.515 . . . . 0.0 107.347 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -67.68 -36.29 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 m170 72.79 -50.14 0.7 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-N 121.898 2.136 . . . . 0.0 111.807 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 71.92 132.34 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.757 0 C-N-CA 127.296 2.239 . . . . 0.0 114.556 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 68.33 57.4 0.46 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 128.502 2.721 . . . . 0.0 113.568 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -179.56 -62.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 123.76 0.824 . . . . 0.0 112.284 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.02 -10.12 12.9 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 12' ' ' ALA . 15.1 t -69.44 134.72 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.039 0 CA-C-N 124.508 3.322 . . . . 0.0 115.679 -172.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.6 -50.83 2.19 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 127.202 2.201 . . . . 0.0 109.901 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -80.55 -0.31 37.09 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -137.64 -109.11 0.18 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 118.034 2.605 . . . . 0.0 118.034 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.07 15.46 26.38 Favored 'General case' 0 N--CA 1.497 1.915 1 N-CA-C 121.839 4.014 . . . . 0.0 121.839 -172.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.21 11.08 26.86 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 121.686 2.039 . . . . 0.0 110.889 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -171.51 -29.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.98 0 C-N-CA 128.436 2.694 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.87 63.26 0.75 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 121.807 2.094 . . . . 0.0 110.42 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m 42.77 46.68 4.54 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -82.19 -23.97 35.21 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 119.228 -2.17 . . . . 0.0 114.135 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.61 33.89 17.45 Favored 'General case' 0 N--CA 1.523 3.216 0 CA-C-N 121.966 2.166 . . . . 0.0 114.566 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.29 -47.7 0.05 OUTLIER Glycine 0 CA--C 1.558 2.732 0 C-N-CA 128.143 2.782 . . . . 0.0 108.605 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 74.59 87.13 0.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 127.496 2.318 . . . . 0.0 114.539 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.6 -43.97 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.427 0 CA-C-N 112.197 -2.274 . . . . 0.0 105.342 173.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.93 74.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.083 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 167.02 -137.43 4.63 Favored Glycine 0 CA--C 1.546 1.974 0 O-C-N 121.172 -0.955 . . . . 0.0 113.195 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -157.5 -37.87 0.07 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.569 1.682 0 CA-C-O 125.01 2.338 . . . . 0.0 114.596 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 40.5 t80 . . . . . 0 CA--C 1.563 1.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.06 98.4 2.57 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 m -105.03 -54.64 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.077 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 61.64 3.78 0.92 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 121.121 1.782 . . . . 0.0 115.299 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 m170 67.19 117.01 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 128.977 2.911 . . . . 0.0 114.673 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.24 54.2 3.31 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 111.782 -2.463 . . . . 0.0 113.325 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -97.31 -59.98 1.67 Allowed 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pp -169.1 -10.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 12' ' ' ALA . 2.3 t -78.24 126.94 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 125.913 2.768 . . . . 0.0 117.991 -171.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.62 -5.26 32.16 Favored 'General case' 0 CA--C 1.589 2.475 0 CA-C-N 109.826 -3.352 . . . . 0.0 113.586 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.583 ' H ' HG12 ' A' ' 9' ' ' VAL . 30.4 p90 -130.79 18.1 5.16 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.003 2.121 . . . . 0.0 113.647 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.658 ' HB3' HG11 ' A' ' 9' ' ' VAL . . . -143.49 -105.54 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 121.254 1.843 . . . . 0.0 115.676 -175.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.99 12.56 4.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -83.63 20.58 1.38 Allowed 'General case' 0 N--CA 1.517 2.881 0 O-C-N 119.424 -2.048 . . . . 0.0 113.611 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p 168.47 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 C-N-CA 131.641 3.976 . . . . 0.0 107.624 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.59 61.79 0.54 Allowed Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.678 1.581 . . . . 0.0 111.209 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t 51.18 25.56 2.48 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -106.12 107.04 17.84 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-N 123.027 2.649 . . . . 0.0 107.272 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -57.35 -32.81 67.11 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.42 -45.86 44.51 Favored Glycine 0 CA--C 1.563 3.086 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 71.11 106.08 0.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.492 2.317 . . . . 0.0 116.624 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.77 -38.12 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.389 0 CA-C-N 111.879 -2.419 . . . . 0.0 106.519 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mt -124.62 76.21 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.978 0 CA-C-N 119.84 1.2 . . . . 0.0 108.942 177.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.91 58.37 0.05 OUTLIER Glycine 0 N--CA 1.493 2.466 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.485 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -45.14 121.59 2.94 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 122.052 0.93 . . . . 0.0 110.804 -179.377 . . . . . . . . 0 0 . 1 stop_ save_